TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
Reduce your risk when donating: see where the money actually goes.
Cite this
Plain text TRANSLATIONAL GENOMICS RESEARCH INSTITUTE. furp.org, nonprofit organization profile, tax years 2009–2024. https://furp.org/org/translational-genomics-research-institute-753065445. Retrieved 2026-11-06.
APA furp.org. (n.d.). TRANSLATIONAL GENOMICS RESEARCH INSTITUTE [Nonprofit organization profile; tax years 2009–2024]. Retrieved November 6, 2026, from https://furp.org/org/translational-genomics-research-institute-753065445
MLA “TRANSLATIONAL GENOMICS RESEARCH INSTITUTE.” furp.org, tax years 2009–2024, https://furp.org/org/translational-genomics-research-institute-753065445. Accessed 6 Nov. 2026.
Retrieved 2026-11-06; covers tax years 2009–2024. Data: furp.org (index © the FURP Alliance; the records are public domain).
2024 · Form 990 · revenue $75.9M · expenses $86.3M · assets $136.1M
- EIN
- 75-3065445
- Address
- 445 N 5TH ST STE 600, PHOENIX, AZ 85004-2274
- Website
- WWW.TGEN.ORG
- NTEE code
- H90 Medical Disciplines Research (Medical Research) published (IRS Business Master File)
- FURP topic
- abuse: substance · launch: launch · science: research education · space: outer · women: issues (from its 990 text; the topic index)
- Exempt type
- 501(c)(3): charitable, religious, educational, scientific or literary (corporation)
- Ruling date
- December 2002 (when the IRS recognized its exemption)
- IRS status
- Exempt (unconditional) (IRS Business Master File) IRS data ↗
- Tax-deductible donations
- Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
- Foundation status
- Public charity supported by the public (170(b)(1)(a)(vi))
- Cross-check
- ProPublica Nonprofit Explorer
Mission
PLEASE SEE SCHEDULE O
Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).
People paid by the organization
53 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.
| Name | Latest title | Years | Latest year pay | Total pay from here | Organizations |
|---|---|---|---|---|---|
| Robert W Stone | BD & VICE CHRM/COH CEO & PRES. | 2016-2024 | $7,115,857 | $39,048,744 | 9 |
| Jeffrey M Trent Phd | BOARD MEMBER/PRES/SCIENCE DIR. | 2009-2024 | $2,031,265 | $20,008,678 | 4 |
| Daniel Von Hoff | TGEN DISTINGUISHED PROFESSOR AND EXECUTIVE VICE PRESIDENT, MOLECULAR MEDICINE DIVISION | 2009-2024 | $1,028,476 | $12,340,753 | 1 |
| Jennifer Parkhurst | TREASURER/COH CFO (PT YR) | 2017-2024 | $1,250,023 | $11,749,544 | 9 |
| Teresa Burleson | CHIEF OPERATING OFFICER | 2009-2024 | $952,505 | $9,605,637 | 2 |
| Michael Berens | DEPUTY DIRECTOR, STRATEGIC INITIATIVES | 2009-2024 | $536,003 | $6,492,673 | 2 |
| Cristin Ocallahan | SECRETARY/COH GENERAL COUNSEL | 2021-2024 | $1,606,017 | $4,955,804 | 9 |
| Sunil Sharma | PHYSICIAN IN CHIEF | 2017-2024 | $645,026 | $4,590,845 | 1 |
| Stephanie Mcrae | GENERAL COUNSEL/ASST SECRETARY | 2010-2024 | $483,182 | $4,453,224 | 1 |
| Manuel Estrada | CFO/ASSISTANT TREASURER | 2014-2024 | $583,868 | $4,223,087 | 2 |
| Nicholas Schork | DEPUTY DIRECTOR, QUANTITATIVE SCIENCES | 2019-2024 | $511,837 | $2,350,228 | 1 |
| Galen Perry | SR. VP OF MKTG & COMMUNICATION | 2011-2024 | $390,683 | $1,856,553 | 1 |
| Cristian Tomasetti | PROFESSOR | 2023-2024 | $549,526 | $1,290,393 | 1 |
| Matt Huentelman | DIVISION DIRECTOR, NEUROGENETICS | 2023-2024 | $484,565 | $985,527 | 1 |
| Yvette Tremonti | COH CHIEF FINANCIAL OFFICER, TREASURER | 2024 | $952,183 | $952,183 | 12 |
| Kevin Campbell | CHIEF INFORMATION OFFICER | 2022-2024 | $336,804 | $934,248 | 2 |
| Aleksandar Sekulic | PROFESSOR | 2024 | $567,135 | $567,135 | 1 |
| Stephanie Pond | VICE PRESIDENT, EMERGING OPPORTUNITIES | 2024 | $482,727 | $482,727 | 1 |
| Robert Kennedy | VICE PRESIDENT, FINANCE | 2024 | $374,560 | $374,560 | 1 |
| Gregory D Schetina (former) | FORMER OFFICER | 2016-2022 | $183,976 | $7,490,410 | 5 |
| Cornelis Van den Berg (former) | FORMER OFFICER | 2016-2021 | $847,476 | $4,589,128 | 5 |
| Timothy Mcdaniel (former) | SR. VP OF EMERG OPP | 2016-2022 | $701,927 | $2,899,650 | 2 |
| James Lowey (former) | CHIEF INFORMATION OFFICER (PT YR) | 2013-2022 | $252,339 | $2,674,484 | 1 |
| John Carpten (former) | Deputy Director of Sciences | 2009-2015 | $701,956 | $2,662,958 | 1 |
| Kendall Jensen (former) | DEPUTY DIR. OF RESEARCH RES. | 2018-2023 | $443,347 | $2,197,128 | 1 |
| Patrick Smith (former) | VP, CORPORATE DEVELOPMENT | 2013-2016 | $357,022 | $2,148,072 | 1 |
| David Duggan (former) | Associate Professor | 2010-2018 | $243,485 | $2,021,959 | 1 |
| Tania Contente-Cuomo (former) | PROGRAM MANAGER - BLOOD LIQUID BIOPSY | 2022 | $1,962,227 | $1,962,227 | 1 |
| David Craig (former) | DEPUTY DIRECTOR OF INFORMATICS | 2011-2016 | $151,891 | $1,943,178 | 2 |
| Spyro Mousses (former) | Vice President | 2009-2013 | $588,446 | $1,482,916 | 1 |
| Thomas Royce (former) | EXEC. DIR OF EMERG OPP (PT YR) | 2017-2020 | $398,999 | $1,456,314 | 1 |
| James Harris (former) | VP, Business Development | 2009-2015 | $229,609 | $1,413,724 | 1 |
| Bradon Mcdonald (former) | COMPUTATIONAL SCIENTIST II | 2022 | $1,364,858 | $1,364,858 | 1 |
| Johanna Distefano (former) | PROFESSOR | 2011-2019 | $267,416 | $1,231,619 | 1 |
| Maria Perdigones (former) | STAFF SCIENTIST | 2022 | $1,169,878 | $1,169,878 | 1 |
| Janine LoBello (former) | Ashion Clinical Lab Director | 2017-2020 | $339,906 | $1,137,945 | 1 |
| Elizabeth Montemayor (former) | CFO (THRU 03/15/13) | 2009-2013 | $279,284 | $1,081,321 | 2 |
| Edward Suh (former) | Chief Information Officer | 2009-2013 | $139,307 | $1,072,880 | 1 |
| Jeffry M Trent PhD (former) | BOARD MEMBER/PRES/SCIENCE DIR. | 2017 | $1,069,784 | $1,069,784 | 2 |
| Michael Bittner (former) | Professor | 2013-2017 | $232,521 | $929,478 | 1 |
| Julia Bridge (former) | Professor | 2019-2020 | $439,012 | $840,742 | 1 |
| Cheryl Babo (former) | GENERAL COUNSEL, ASSOCIATE | 2021-2023 | $375,624 | $750,799 | 1 |
| Ahuva Odenheimer (former) | BIOINFORMATICIAN | 2022 | $584,939 | $584,939 | 1 |
| Charles K Coleson (former) | CHIEF FINANCIAL OFFICER | 2013-2015 | $159,796 | $575,370 | 2 |
| Stephen Gately (former) | TD2 PRESIDENT / SCIENTIFIC DIR | 2010-2011 | $252,686 | $475,489 | 1 |
| David Haworth (former) | PRESIDENT, VIDIUM | 2021 | $465,432 | $465,432 | 1 |
| Tess Burleson (former) | CHIEF OPERATING OFFICER | 2010 | $460,018 | $460,018 | 2 |
| Edward Shaffer (former) | VP, TECHNOLOGY STRATEGY AND INNOVATION | 2021 | $346,160 | $346,160 | 1 |
| Jeffrey Nieves (former) | DEPUTY DIRECTOR (THRU 11/2011) | 2011 | $310,929 | $310,929 | 1 |
| David Cooper (former) | Ashion Medical Director | 2017 | $282,676 | $282,676 | 1 |
| Steve Day (former) | DIRECTOR, SOFTWARE ENGINEERING | 2010 | $219,104 | $219,104 | 1 |
| Janine Tilli (former) | VICE PRESIDENT, HUMAN RESOURCE | 2010 | $215,462 | $215,462 | 1 |
| Mary Anne Guerra (former) | PRESIDENT, TGEN ACCELERATORS | 2009 | $119,543 | $119,543 | 1 |
Officers and directors, no compensation reported
36 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.
| Name | Latest title | Years | Hrs/wk (latest) | Compensation | Organizations |
|---|---|---|---|---|---|
| Sharon Harper | BOARD MEMBER | 2017-2024 | 1 | $0 reported | 5 |
| Bennett Dorrance | BOARD MEMBER | 2009-2024 | 1 | $0 reported | 3 |
| William J Post | BOARD MEMBER/CHAIRMAN | 2009-2024 | 1 | $0 reported | 7 |
| Anthony Scott | BOARD MEMBER | 2018-2024 | 1 | $0 reported | 2 |
| David J Gullen Md | BOARD MEMBER | 2009-2024 | 1 | $0 reported | 1 |
| Karen Quintos | BOARD MEMBER | 2021-2024 | 1 | $0 reported | 1 |
| Marilyn Quayle | BOARD MEMBER | 2017-2024 | 1 | $0 reported | 1 |
| Pamela Kehaly | BOARD MEMBER | 2018-2024 | 1 | $0 reported | 1 |
| Richard Silverman | BOARD MEMBER | 2009-2024 | 1 | $0 reported | 1 |
| Terry Peets | BOARD MEMBER | 2016-2024 | 1 | $0 reported | 2 |
| Cindy Parseghian (former) | Board Member | 2009-2020 | 1 | $0 reported | 1 |
| Robert Bulla (former) | BOARD MEMBER | 2009-2019 | 1 | $0 reported | 1 |
| Richard L Boals (former) | Board Member | 2013-2017 | 1 | $0 reported | 1 |
| Jeffrey Moorad (former) | Board Member | 2009-2017 | 1 | $0 reported | 1 |
| The Honorable Greg Stanton (former) | Board Member (Thru 5/18) | 2010-2017 | 1 | $0 reported | 1 |
| Governor Jan Brewer (former) | Board Member (THRU 1/9/15) | 2009-2015 | 1 | $0 reported | 1 |
| Bert A Getz (former) | Board Member (THRU 10/13/15) | 2009-2015 | 1 | $0 reported | 1 |
| Peter S Fine (former) | BOARD MEMBER (THRU 2/14) | 2009-2014 | 1 | $0 reported | 1 |
| Jerry Bisgrove (former) | Board Member (PART YEAR) | 2011-2013 | 1 | $0 reported | 2 |
| Jose Cardenas (former) | Board Member (PART YEAR) | 2009-2013 | 1 | $0 reported | 3 |
| T Lon Owen PhD (former) | Board Member (PART YEAR) | 2009-2013 | 1 | $0 reported | 1 |
| David Van Andel (former) | BOARD MEMBER (THRU 3/2012) | 2009-2011 | 1 | $0 reported | 5 |
| John Kennedy (former) | BOARD MEMBER (THRU 3/2012) | 2009-2011 | 1 | $0 reported | 1 |
| Governer Jan Brewer (former) | BOARD MEMBER | 2010 | 1 | $0 reported | 1 |
| Michael Crow (former) | DIRECTOR | 2009 | 1 | $0 reported | 11 |
| Honorable Phil Gordon (former) | DIRECTOR | 2009 | 1 | $0 reported | 1 |
| Betsey Bayless (former) | DIRECTOR | 2009 | 1 | $0 reported | 1 |
| R Richard L Boals (former) | DIRECTOR | 2009 | 1 | $0 reported | 1 |
| Susan Clark Johnson (former) | DIRECTOR | 2009 | 1 | $0 reported | 1 |
| Honorable Diane Enos (former) | DIRECTOR | 2009 | 1 | $0 reported | 1 |
| John D Haeger Phd (former) | DIRECTOR | 2009 | 1 | $0 reported | 1 |
| John Murphy (former) | DIRECTOR | 2009 | 1 | $0 reported | 1 |
| Keith R Mckennon (former) | DIRECTOR | 2009 | 1 | $0 reported | 1 |
| Franklyn G Prendergast Md Phd (former) | DIRECTOR | 2009 | 1 | $0 reported | 1 |
| Robert N Shelton Phd (former) | DIRECTOR | 2009 | 1 | $0 reported | 1 |
| Honorable Jim Slattery (former) | DIRECTOR | 2009 | 1 | $0 reported | 1 |
People by year
2024 · 29 people listed · 19 paid, $20.9M · 406 employees · 70 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| ROBERT W STONE | BD & VICE CHRM/COH CEO & PRES. | 1 | $0 | $6,085,650 | $1,030,207 | $7,115,857 | 9 |
| JEFFREY M TRENT PHD | BOARD MEMBER/PRES/SCIENCE DIR. | 39 | $0 | $1,780,335 | $250,930 | $2,031,265 | 4 |
| CRISTIN O'CALLAHAN | SECRETARY/COH GENERAL COUNSEL | 1 | $0 | $1,355,050 | $250,967 | $1,606,017 | 9 |
| JENNIFER A PARKHURST | TREASURER/COH CFO (PT YR) | 0 | $0 | $1,211,996 | $38,027 | $1,250,023 | 9 |
| DANIEL VON HOFF | TGEN DISTINGUISHED PROFESSOR AND EXECUTIVE VICE PRESIDENT, MOLECULAR MEDICINE DIVISION | 40 | $1,004,466 | $0 | $24,010 | $1,028,476 | 1 |
| TERESA BURLESON | CHIEF OPERATING OFFICER | 39 | $873,875 | $0 | $78,630 | $952,505 | 2 |
| YVETTE TREMONTI | COH CHIEF FINANCIAL OFFICER, TREASURER | 1 | $0 | $864,143 | $88,040 | $952,183 | 12 |
| SUNIL SHARMA | PHYSICIAN IN CHIEF | 40 | $612,635 | $0 | $32,391 | $645,026 | 1 |
| MANUEL ESTRADA | CFO/ASSISTANT TREASURER | 39 | $518,852 | $0 | $65,016 | $583,868 | 2 |
| ALEKSANDAR SEKULIC | PROFESSOR | 1 | $552,402 | $0 | $14,733 | $567,135 | 1 |
| CRISTIAN TOMASETTI | PROFESSOR | 40 | $471,190 | $0 | $78,336 | $549,526 | 1 |
| MICHAEL BERENS | DEPUTY DIRECTOR, STRATEGIC INITIATIVES | 40 | $502,745 | $0 | $33,258 | $536,003 | 2 |
| NICHOLAS SCHORK | DEPUTY DIRECTOR, QUANTITATIVE SCIENCES | 40 | $492,859 | $0 | $18,978 | $511,837 | 1 |
| MATT HUENTELMAN | DIVISION DIRECTOR, NEUROGENETICS | 40 | $416,286 | $0 | $68,279 | $484,565 | 1 |
| STEPHANIE MCRAE | GENERAL COUNSEL/ASST SECRETARY | 40 | $461,002 | $0 | $22,180 | $483,182 | 1 |
| STEPHANIE POND | VICE PRESIDENT, EMERGING OPPORTUNITIES | 40 | $463,550 | $0 | $19,177 | $482,727 | 1 |
| GALEN PERRY | SR. VP OF MKTG & COMMUNICATION | 40 | $358,157 | $0 | $32,526 | $390,683 | 1 |
| ROBERT KENNEDY | VICE PRESIDENT, FINANCE | 40 | $354,169 | $0 | $20,391 | $374,560 | 1 |
| KEVIN CAMPBELL | CHIEF INFORMATION OFFICER | 40 | $310,653 | $0 | $26,151 | $336,804 | 2 |
| WILLIAM J POST | BOARD MEMBER/CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 7 |
| ANTHONY SCOTT | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 2 |
| BENNETT DORRANCE | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 3 |
| DAVID J GULLEN MD | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| KAREN QUINTOS | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| MARILYN QUAYLE | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| PAMELA KEHALY | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD SILVERMAN | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| SHARON HARPER | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 5 |
| TERRY PEETS | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 2 |
2023 · 27 people listed · 17 paid, $18.0M · 463 employees · 52 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| ROBERT W STONE | BD & VICE CHRM/COH CEO & PRES. | 1 | $0 | $4,482,649 | $1,667,331 | $6,149,980 | 9 |
| JEFFREY M TRENT PHD | BOARD MEMBER/PRES/SCIENCE DIR. | 39 | $0 | $1,532,966 | $343,288 | $1,876,254 | 4 |
| JENNIFER A PARKHURST | TREASURER/COH CFO (PT YR) | 1 | $0 | $1,564,286 | $64,844 | $1,629,130 | 9 |
| CRISTIN O'CALLAHAN | SECRETARY/COH GENERAL COUNSEL | 1 | $0 | $1,131,338 | $341,123 | $1,472,461 | 9 |
| DANIEL VON HOFF | PHYSICIAN IN CHIEF | 40 | $825,361 | $0 | $23,105 | $848,466 | 1 |
| TERESA BURLESON | CHIEF OPERATING OFFICER | 39 | $718,000 | $0 | $31,378 | $749,378 | 2 |
| CRISTIAN TOMASETTI | PROFESSOR | 40 | $632,656 | $0 | $108,211 | $740,867 | 1 |
| SUNIL SHARMA | DEPUTY DIR OF CLINIC. SCIENCES | 40 | $612,970 | $0 | $29,636 | $642,606 | 1 |
| MATT HUENTELMAN | PROFESSOR | 40 | $437,867 | $0 | $63,095 | $500,962 | 1 |
| MICHAEL BERENS | DEPUTY DIRECTOR OF RESEARCH | 40 | $468,875 | $0 | $31,435 | $500,310 | 2 |
| NICHOLAS SCHORK | PROFESSOR | 40 | $460,472 | $0 | $21,344 | $481,816 | 1 |
| MANUEL ESTRADA | CFO/ASSISTANT TREASURER | 39 | $439,142 | $0 | $36,511 | $475,653 | 2 |
| KENDALL JENSEN | DEPUTY DIR. OF RESEARCH RES. | 40 | $408,623 | $0 | $34,724 | $443,347 | 1 |
| GALEN PERRY | SR. VP OF MKTG & COMMUNICATION | 40 | $392,474 | $0 | $33,590 | $426,064 | 1 |
| STEPHANIE MCRAE | GENERAL COUNSEL/ASST SECRETARY | 40 | $383,664 | $0 | $24,503 | $408,167 | 1 |
| CHERYL BABO | GENERAL COUNSEL, ASSOCIATE | 40 | $360,307 | $0 | $15,317 | $375,624 | 1 |
| KEVIN CAMPBELL | CHIEF INFORMATION OFFICER | 40 | $275,299 | $0 | $25,617 | $300,916 | 2 |
| WILLIAM J POST | BOARD MEMBER/CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 7 |
| ANTHONY SCOTT | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 2 |
| BENNETT DORRANCE | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 3 |
| DAVID J GULLEN MD | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| KAREN QUINTOS | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| MARILYN QUAYLE | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| PAMELA KEHALY | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD SILVERMAN | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| SHARON HARPER | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 5 |
| TERRY PEETS | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 2 |
2022 · 29 people listed · 19 paid, $20.5M · 496 employees · 50 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| ROBERT W STONE | BD & VICE CHRM/COH CEO & PRES. | 1 | $0 | $4,316,431 | $814,563 | $5,130,994 | 9 |
| JENNIFER A PARKHURST | TREASURER/COH CFO (PT YR) | 1 | $0 | $2,064,500 | $143,720 | $2,208,220 | 9 |
| TANIA CONTENTE-CUOMO | PROGRAM MANAGER - BLOOD LIQUID BIOPSY | 40 | $1,938,394 | $0 | $23,833 | $1,962,227 | 1 |
| JEFFREY M TRENT PHD | BOARD MEMBER/PRES/SCIENCE DIR. | 39 | $0 | $1,194,012 | $258,282 | $1,452,294 | 4 |
| BRADON MCDONALD | COMPUTATIONAL SCIENTIST II | 40 | $1,364,858 | $0 | $0 | $1,364,858 | 1 |
| CRISTIN O'CALLAHAN | SECRETARY/COH GENERAL COUNSEL | 1 | $0 | $990,340 | $190,870 | $1,181,210 | 9 |
| MARIA PERDIGONES | STAFF SCIENTIST | 40 | $1,169,878 | $0 | $0 | $1,169,878 | 1 |
| DANIEL VON HOFF | PHYSICIAN IN CHIEF | 40 | $807,772 | $0 | $23,197 | $830,969 | 1 |
| TERESA BURLESON | CHIEF OPERATING OFFICER | 39 | $693,598 | $0 | $25,197 | $718,795 | 2 |
| TIMOTHY MCDANIEL | SR. VP OF EMERG OPP | 40 | $701,927 | $0 | $0 | $701,927 | 2 |
| SUNIL SHARMA | DEPUTY DIR OF CLINIC. SCIENCES | 40 | $626,245 | $0 | $25,431 | $651,676 | 1 |
| AHUVA ODENHEIMER | BIOINFORMATICIAN | - | $584,939 | $0 | $0 | $584,939 | 1 |
| MICHAEL BERENS | DEPUTY DIRECTOR OF RESEARCH | 40 | $460,036 | $0 | $29,806 | $489,842 | 2 |
| MANUEL ESTRADA | CFO/ASSISTANT TREASURER | 39 | $423,372 | $0 | $24,929 | $448,301 | 2 |
| KENDALL JENSEN | DEPUTY DIR. OF RESEARCH RES. | 40 | $417,331 | $0 | $25,983 | $443,314 | 1 |
| STEPHANIE MCRAE | GENERAL COUNSEL/ASST SECRETARY | 40 | $405,364 | $0 | $25,198 | $430,562 | 1 |
| KEVIN CAMPBELL | CHIEF INFORMATION OFFICER (PT YR) | 40 | $272,043 | $0 | $24,485 | $296,528 | 2 |
| JAMES LOWEY | CHIEF INFORMATION OFFICER (PT YR) | 40 | $235,100 | $0 | $17,239 | $252,339 | 1 |
| GREGORY D SCHETINA | FORMER OFFICER | 1 | $0 | $183,976 | $0 | $183,976 | 5 |
| WILLIAM J POST | BOARD MEMBER/CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 7 |
| ANTHONY SCOTT | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 2 |
| BENNETT DORRANCE | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 3 |
| DAVID J GULLEN MD | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| KAREN QUINTOS | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| MARILYN QUAYLE | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| PAMELA KEHALY | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD SILVERMAN | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| SHARON HARPER | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 5 |
| TERRY PEETS | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 2 |
2021 · 30 people listed · 20 paid, $19.4M · 450 employees · 42 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| ROBERT W STONE | BD & VICE CHRM/COH CEO & PRES. | 1 | $0 | $3,468,047 | $645,461 | $4,113,508 | 9 |
| JENNIFER A PARKHURST | TREASURER/COH CFO | 1 | $0 | $1,907,352 | $274,536 | $2,181,888 | 9 |
| JEFFREY M TRENT PHD | BOARD MEMBER/PRES/SCIENCE DIR. | 39 | $0 | $1,756,429 | $258,536 | $2,014,965 | 4 |
| GREGORY D SCHETINA | SECRETARY/COH GENERAL COUNSEL (PT YR) | 1 | $0 | $1,266,856 | $184,060 | $1,450,916 | 5 |
| TERESA BURLESON | CHIEF OPERATING OFFICER | 39 | $1,071,675 | $0 | $24,475 | $1,096,150 | 2 |
| DANIEL VON HOFF | PHYSICIAN IN CHIEF | 40 | $954,505 | $0 | $22,755 | $977,260 | 1 |
| Cornelis Van den Berg | FORMER OFFICER | 0 | $0 | $768,960 | $78,516 | $847,476 | 5 |
| SUNIL SHARMA | DEPUTY DIR OF CLINIC. SCIENCES | 40 | $720,379 | $0 | $23,715 | $744,094 | 1 |
| CRISTIN O'CALLAHAN | SECRETARY/COH GENERAL COUNSEL | 1 | $0 | $574,556 | $121,560 | $696,116 | 9 |
| MICHAEL BERENS | DEPUTY DIRECTOR OF RESEARCH | 40 | $578,935 | $0 | $29,175 | $608,110 | 2 |
| TIMOTHY MCDANIEL | SR. VP OF EMERG. OPP | 40 | $571,482 | $0 | $13,348 | $584,830 | 2 |
| MANUEL ESTRADA | CFO/ASSISTANT TREASURER | 39 | $549,445 | $0 | $18,898 | $568,343 | 2 |
| STEPHANIE MCRAE | GENERAL COUNSEL/ASST SECRETARY | 40 | $535,094 | $0 | $16,353 | $551,447 | 1 |
| NICHOLAS SCHORK | PROFESSOR | 40 | $514,470 | $0 | $17,475 | $531,945 | 1 |
| DAVID HAWORTH | PRESIDENT, VIDIUM | 40 | $439,713 | $0 | $25,719 | $465,432 | 1 |
| JAMES LOWEY | CHIEF INFORMATION OFFICER | 40 | $432,851 | $0 | $22,299 | $455,150 | 1 |
| KENDALL JENSEN | DEPUTY DIR. OF RESEARCH RES. | 40 | $426,683 | $0 | $23,791 | $450,474 | 1 |
| CHERYL BABO | GENERAL COUNSEL, ASSOCIATE | 40 | $349,786 | $0 | $25,389 | $375,175 | 1 |
| EDWARD SHAFFER | VP, TECHNOLOGY STRATEGY AND INNOVATION | 40 | $330,117 | $0 | $16,043 | $346,160 | 1 |
| GALEN PERRY | SR. VP OF MKTG & COMMUNICATION | 40 | $304,957 | $0 | $26,893 | $331,850 | 1 |
| WILLIAM J POST | BOARD MEMBER/CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 7 |
| ANTHONY SCOTT | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 2 |
| BENNETT DORRANCE | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 3 |
| DAVID J GULLEN MD | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| KAREN QUINTOS | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| MARILYN QUAYLE | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| PAMELA KEHALY | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD SILVERMAN | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| SHARON HARPER | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 5 |
| TERRY PEETS | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 2 |
2020 · 29 people listed · 19 paid, $15.1M · 469 employees · 48 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Robert Stone | BD & VICE CHRM/COH CEO & PRES. | 1 | $0 | $3,147,496 | $558,067 | $3,705,563 | 9 |
| Jennifer Parkhurst | Treasurer/COH CFO | 1 | $0 | $1,374,742 | $313,357 | $1,688,099 | 9 |
| Jeffrey M Trent PhD | BOARD MEMBER/PRES/SCIENCE DIR. | 39 | $0 | $1,047,178 | $249,398 | $1,296,576 | 4 |
| Gregory Schetina | Secretary/COH General COUNSEL | 1 | $0 | $1,043,947 | $215,265 | $1,259,212 | 5 |
| Teresa Burleson | Chief Operating Officer | 39 | $873,615 | $0 | $23,532 | $897,147 | 2 |
| Daniel Von Hoff | Physician in Chief | 40 | $754,185 | $0 | $71,832 | $826,017 | 1 |
| Cornelis Van Den Berg | Former Officer | 0 | $0 | $631,148 | $74,749 | $705,897 | 5 |
| Sunil Sharma | DEPUTY DIR OF CLINIC. SCIENCES | 40 | $580,764 | $0 | $22,636 | $603,400 | 1 |
| Julia Bridge | Professor | 40 | $419,925 | $0 | $19,087 | $439,012 | 1 |
| Michael Berens | Deputy Director of Research | 40 | $403,057 | $0 | $25,120 | $428,177 | 2 |
| Nicholas Schork | Professor | 40 | $404,122 | $0 | $17,054 | $421,176 | 1 |
| Stephanie McRae | GENERAL COUNSEL/ASST SECRETARY | 40 | $395,435 | $0 | $14,428 | $409,863 | 1 |
| Thomas Royce | EXEC. DIR OF EMERG OPP (PT YR) | 40 | $378,862 | $0 | $20,137 | $398,999 | 1 |
| Timothy McDaniel | Sr. VP of EmerG. Opp (PT YR) | 40 | $365,774 | $0 | $20,835 | $386,609 | 2 |
| Manuel Estrada | CFO/Assistant Treasurer | 39 | $352,079 | $0 | $21,354 | $373,433 | 2 |
| Janine LoBello | Ashion Clinical Lab Director | 40 | $321,818 | $0 | $18,088 | $339,906 | 1 |
| Kendall Jensen | DEPUTY DIR. OF RESEARCH RES. | 40 | $307,500 | $0 | $20,586 | $328,086 | 1 |
| James Lowey | Chief Information Officer | 40 | $275,730 | $0 | $21,559 | $297,289 | 1 |
| Galen Perry | Sr. VP of MKTG & Communication | 40 | $263,628 | $0 | $24,154 | $287,782 | 1 |
| William J Post | Board Member/Chairman | 1 | $0 | $0 | $0 | $0 | 7 |
| Bennett Dorrance | Board Member | 1 | $0 | $0 | $0 | $0 | 3 |
| David J Gullen MD | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Sharon Harper | Board Member | 1 | $0 | $0 | $0 | $0 | 5 |
| PAMELA KEHALY | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| CINDY PARSEGHIAN | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| TERRY PEETS | Board Member | 1 | $0 | $0 | $0 | $0 | 2 |
| MARILYN QUAYLE | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| ANTHONY SCOTT | Board Member | 1 | $0 | $0 | $0 | $0 | 2 |
| Richard Silverman | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
2019 · 30 people listed · 19 paid, $15.1M · 419 employees · 62 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| ROBERT STONE | BD & VICE CHRM/COH CEO & PRES. | 1 | $0 | $3,717,559 | $507,612 | $4,225,171 | 9 |
| JENNIFER PARKHURST | TREASURER/COH CFO | 1 | $0 | $1,131,123 | $350,199 | $1,481,322 | 9 |
| JEFFREY M TRENT PHD | BOARD MEMBER/PRES/SCIENCE DIR. | 39 | $0 | $1,332,028 | $52,921 | $1,384,949 | 4 |
| GREGORY SCHETINA | SECRETARY/COH GENERAL COUNSEL | 1 | $0 | $1,060,596 | $195,382 | $1,255,978 | 5 |
| DANIEL VON HOFF | PHYSICIAN IN CHIEF | 40 | $875,090 | $0 | $21,764 | $896,854 | 1 |
| CORNELIS VAN DEN BERG | FORMER TREASURER | 0 | $0 | $697,350 | $54,209 | $751,559 | 5 |
| TERESA BURLESON | CHIEF OPERATING OFFICER | 39 | $534,670 | $0 | $117,669 | $652,339 | 2 |
| SUNIL SHARMA | DEPUTY DIR OF CLINIC. SCIENCES | 40 | $549,285 | $0 | $21,450 | $570,735 | 1 |
| MICHAEL BERENS | DEPUTY DIRECTOR OF RESEARCH | 40 | $488,370 | $0 | $30,518 | $518,888 | 2 |
| NICHOLAS SCHORK | PROFESSOR | 40 | $383,895 | $0 | $19,559 | $403,454 | 1 |
| JULIA BRIDGE | PROFESSOR | 40 | $388,575 | $0 | $13,155 | $401,730 | 1 |
| THOMAS ROYCE | ASHION EXECUTIVE DIRECTOR | 40 | $373,827 | $0 | $21,510 | $395,337 | 1 |
| STEPHANIE MCRAE | GENERAL COUNSEL/ASST SECRETARY | 40 | $328,707 | $0 | $16,464 | $345,171 | 1 |
| MANUEL ESTRADA | CFO/ASSISTANT TREASURER | 39 | $319,895 | $0 | $20,250 | $340,145 | 2 |
| TIMOTHY MCDANIEL | SR. VP OF EMERG. OPPORTUNITIES | 40 | $308,000 | $0 | $23,258 | $331,258 | 2 |
| JAMES LOWEY | CHIEF INFORMATION OFFICER | 40 | $272,259 | $0 | $15,340 | $287,599 | 1 |
| JANINE LOBELLO | ASHION CLINICAL LAB DIRECTOR | 40 | $264,789 | $0 | $14,783 | $279,572 | 1 |
| KENDALL JENSEN | DEPUTY DIR. OF RESEARCH RES. | 40 | $252,861 | $0 | $20,326 | $273,187 | 1 |
| JOHANNA DISTEFANO | PROFESSOR | 40 | $253,879 | $0 | $13,537 | $267,416 | 1 |
| WILLIAM J POST | BOARD MEMBER/CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 7 |
| ROBERT BULLA | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| BENNETT DORRANCE | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 3 |
| DAVID J GULLEN MD | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| SHARON HARPER | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 5 |
| PAMELA KEHALY | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| CINDY PARSEGHIAN | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| TERRY PEETS | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 2 |
| MARILYN QUAYLE | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| ANTHONY SCOTT | Board Member | 1 | $0 | $0 | $0 | $0 | 2 |
| RICHARD SILVERMAN | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
2018 · 29 people listed · 18 paid, $12.7M · 354 employees · 70 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Robert Stone | BD & VICE CHRM/COH CEO & PRES. | 1 | $0 | $2,902,629 | $463,619 | $3,366,248 | 9 |
| Jennifer Parkhurst | Treasurer/COH CFO | 1 | $0 | $1,230,233 | $80,629 | $1,310,862 | 9 |
| Gregory Schetina | Secretary/COH General Counsel | 1 | $0 | $1,005,582 | $187,797 | $1,193,379 | 5 |
| Jeffrey M Trent PhD | Board Member/Pres/Science Dir. | 39 | $0 | $1,023,863 | $47,842 | $1,071,705 | 4 |
| Cornelis Van Den Berg | Former Treasurer | 0 | $0 | $781,103 | $32,318 | $813,421 | 5 |
| Daniel Von Hoff | Physician in Chief | 40 | $740,017 | $0 | $68,930 | $808,947 | 1 |
| Teresa Burleson | Chief Operating Officer | 39 | $566,531 | $0 | $71,245 | $637,776 | 2 |
| Sunil Sharma | Deputy Dir of Clinic. Sciences | 40 | $529,255 | $0 | $12,834 | $542,089 | 1 |
| Michael Berens | Deputy Director of Research | 40 | $396,762 | $0 | $47,997 | $444,759 | 2 |
| Timothy McDaniel | Sr. VP of Emerg. Opportunities | 40 | $329,042 | $0 | $12,647 | $341,689 | 2 |
| Thomas Royce | Ashion Executive Director | 40 | $323,476 | $0 | $9,823 | $333,299 | 1 |
| Manuel Estrada | CFO/Assistant Treasurer | 39 | $310,524 | $0 | $10,912 | $321,436 | 2 |
| James Lowey | Chief Information Officer | 40 | $266,671 | $0 | $2,150 | $268,821 | 1 |
| Janine Lobello | Ashion Clinical Lab Director | 40 | $257,228 | $0 | $4,072 | $261,300 | 1 |
| Kendall Jensen | Professor | 40 | $244,491 | $0 | $14,229 | $258,720 | 1 |
| Johanna DiStefano | Professor | 40 | $246,100 | $0 | $3,619 | $249,719 | 1 |
| David Duggan | Associate Professor | 40 | $229,194 | $0 | $14,291 | $243,485 | 1 |
| Stephanie McRae | GENERAL COUNSEL/ASST SECRETARY | 40 | $214,548 | $0 | $13,655 | $228,203 | 1 |
| William J Post | Board Member/Chairman | 1 | $0 | $0 | $0 | $0 | 7 |
| Robert Bulla | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Bennett Dorrance | Board Member | 1 | $0 | $0 | $0 | $0 | 3 |
| David J Gullen MD | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Sharon Harper | Board Member | 1 | $0 | $0 | $0 | $0 | 5 |
| Pamela Kehaly | BOARD MEMBER(AS of 2/5/19) | 1 | $0 | $0 | $0 | $0 | 1 |
| Cindy Parseghian | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Terry Peets | Board Member | 1 | $0 | $0 | $0 | $0 | 2 |
| Marilyn Quayle | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Anthony Scott | Board Member (AS OF 2/5/19) | 1 | $0 | $0 | $0 | $0 | 2 |
| Richard Silverman | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
2017 · 30 people listed · 17 paid, $10.1M · 298 employees · 62 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Robert Stone | BD & VICE CHRM/COH CEO & PRES | 1 | $0 | $2,281,400 | $433,116 | $2,714,516 | 9 |
| Gregory Schetina | Secretary/ COH General Council | 1 | $0 | $917,810 | $179,708 | $1,097,518 | 5 |
| Jeffry M Trent PhD | BOARD MEMBER/PRES/SCIENCE DIR. | 39 | $0 | $1,019,398 | $50,386 | $1,069,784 | 2 |
| Cornelis Van Den Berg | Tre./COH Int. CFO (Thru 12/17) | 1 | $0 | $783,535 | $66,476 | $850,011 | 5 |
| Daniel Von Hoff | Physician in Chief | 40 | $743,818 | $0 | $20,734 | $764,552 | 1 |
| Teresa Burleson | Chief Operating Officer | 39 | $526,688 | $0 | $21,374 | $548,062 | 2 |
| Michael Berens | Deputy Director of Research | 40 | $400,868 | $0 | $16,557 | $417,425 | 2 |
| Manuel Estrada | CFO/Assistant Treasurer | 39 | $320,061 | $0 | $10,980 | $331,041 | 2 |
| Thomas Royce | Ashion Executive Director | 40 | $321,113 | $0 | $7,566 | $328,679 | 1 |
| Timothy McDaniel | Sr. VP of Emerg. Opportunities | 40 | $279,635 | $0 | $10,042 | $289,677 | 2 |
| David Cooper | Ashion Medical Director | 40 | $282,244 | $0 | $432 | $282,676 | 1 |
| James Lowey | Chief Information Officer | 40 | $280,920 | $0 | $1,608 | $282,528 | 1 |
| Janine Lobello | Ashion Clinic. Laboratory Dir. | 40 | $253,628 | $0 | $3,539 | $257,167 | 1 |
| David Duggan | Associate Professor | 40 | $223,686 | $0 | $12,982 | $236,668 | 1 |
| Michael Bittner | Professor | 40 | $225,551 | $0 | $6,970 | $232,521 | 1 |
| Sunil Sharma | Deputy Dir of Clinic. Sciences | 40 | $188,209 | $0 | $3,010 | $191,219 | 1 |
| Stephanie McRae | Asst. Secretary (EFF 10/17) | 40 | $161,218 | $0 | $12,739 | $173,957 | 1 |
| William J Post | Board Member/Chairman | 1 | $0 | $0 | $0 | $0 | 7 |
| Richard L Boals | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert Bulla | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Bennett Dorrance | Board Member | 1 | $0 | $0 | $0 | $0 | 3 |
| David J Gullen MD | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Sharon Harper | Board Member (EFF 5/18) | 1 | $0 | $0 | $0 | $0 | 5 |
| Jeffrey Moorad | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Cindy Parseghian | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Terry Peets | Board Member | 1 | $0 | $0 | $0 | $0 | 2 |
| Marilyn Quayle | Board Member (EFF 5/18) | 1 | $0 | $0 | $0 | $0 | 1 |
| Richard Silverman | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| The Honorable Greg Stanton | Board Member (Thru 5/18) | 1 | $0 | $0 | $0 | $0 | 1 |
| Jennifer Parkhurst | Treasurer/COH CFO (Eff 2/18) | 1 | $0 | $0 | $0 | $0 | 9 |
2016 · 25 people listed · 15 paid, $9.2M · 326 employees · 68 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Robert Stone | BD & VICE CHRM/COH CEO & PRES | 1 | $0 | $2,147,991 | $378,916 | $2,526,907 | 9 |
| Jeffrey M Trent PhD | Board Member/Pres/ScienCE DIR. | 39 | $1,279,662 | $0 | $18,768 | $1,298,430 | 4 |
| GREGORY SCHETINA | SECRETARY/COH GENERAL COUNSEL | 1 | $0 | $893,238 | $156,193 | $1,049,431 | 5 |
| Daniel Von Hoff | Physician in Chief | 40 | $650,548 | $0 | $62,948 | $713,496 | 1 |
| CORNELIS VAN DEN BERG | TREASURER/COH INTERIM CFO | 1 | $0 | $555,703 | $65,061 | $620,764 | 5 |
| Teresa Burleson | Chief Operating Officer | 39 | $485,078 | $0 | $68,969 | $554,047 | 2 |
| Michael Berens | Deputy Director of Research | 40 | $335,398 | $0 | $51,455 | $386,853 | 2 |
| Patrick Smith | VP, CORPORATE DEVELOPMENT | 40 | $353,583 | $0 | $3,439 | $357,022 | 1 |
| Manuel Estrada | Chief Financial Officer | 39 | $278,403 | $0 | $18,616 | $297,019 | 2 |
| Timothy McDaniel | Sr. VP of Emerging OPS | 40 | $244,168 | $0 | $19,492 | $263,660 | 2 |
| Stephanie McRae | General Counsel | 40 | $242,371 | $0 | $19,150 | $261,521 | 1 |
| David Duggan | Associate Professor | 40 | $216,142 | $0 | $23,133 | $239,275 | 1 |
| Michael Bittner | Professor | 40 | $219,177 | $0 | $17,426 | $236,603 | 1 |
| James Lowey | Chief Information Officer | 40 | $216,001 | $0 | $11,011 | $227,012 | 1 |
| DAVID CRAIG | DEPUTY DIRECTOR OF INFORMATICS | 40 | $141,723 | $0 | $10,168 | $151,891 | 2 |
| William J Post | Board Member/Chairman | 1 | $0 | $0 | $0 | $0 | 7 |
| Cindy Parseghian | Board Member/Treasurer | 1 | $0 | $0 | $0 | $0 | 1 |
| Bennett Dorrance | Board Member/Secretary | 1 | $0 | $0 | $0 | $0 | 3 |
| Richard L Boals | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert Bulla | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| David J Gullen MD | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Jeffrey Moorad | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Terry Peets | Board Member | 1 | $0 | $0 | $0 | $0 | 2 |
| Richard Silverman | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| The Honorable Greg Stanton | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
2015 · 24 people listed · 13 paid, $6.5M · 345 employees · 70 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Jeffrey M Trent PhD | BOARD MEMBER/PRES/SCIENCE DIR. | 39 | $999,967 | $0 | $220,796 | $1,220,763 | 4 |
| Patrick Smith | VP, Corporate Development | 40 | $641,343 | $0 | $244,600 | $885,943 | 1 |
| Daniel Von Hoff | Executive Vice President | 40 | $817,646 | $0 | $17,297 | $834,943 | 1 |
| John Carpten | Deputy Director of Sciences | 40 | $680,856 | $0 | $21,100 | $701,956 | 1 |
| Teresa Burleson | CHIEF OPERATING OFFICER | 39 | $547,980 | $0 | $55,384 | $603,364 | 2 |
| David Craig | Deputy Director of Informatics | 40 | $574,701 | $0 | $20,531 | $595,232 | 2 |
| Michael Berens | Deputy Director of Research | 40 | $345,423 | $0 | $19,851 | $365,274 | 2 |
| Manuel Estrada | Vice President, Finance | 40 | $232,636 | $0 | $16,367 | $249,003 | 2 |
| David Duggan | Associate Professor | 40 | $225,575 | $0 | $22,475 | $248,050 | 1 |
| Michael Bittner | Professor | 40 | $225,431 | $0 | $16,465 | $241,896 | 1 |
| James Harris | VP, Business Development | 40 | $218,448 | $0 | $11,161 | $229,609 | 1 |
| James Lowey | Vice President, Technology | 40 | $199,488 | $0 | $9,475 | $208,963 | 1 |
| CHARLES K COLESON | CHIEF FINANCIAL OFFICER | 29 | $157,822 | $0 | $1,974 | $159,796 | 2 |
| William J Post | Board Member/Chairman | 1 | $0 | $0 | $0 | $0 | 7 |
| Cindy Parseghian | Board Member/Treasurer | 1 | $0 | $0 | $0 | $0 | 1 |
| Bennett Dorrance | Board Member /Secretary | 1 | $0 | $0 | $0 | $0 | 3 |
| Richard L Boals | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Governor Jan Brewer | Board Member (THRU 1/9/15) | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert Bulla | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Bert A Getz | Board Member (THRU 10/13/15) | 1 | $0 | $0 | $0 | $0 | 1 |
| David J Gullen MD | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Jeffrey Moorad | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Richard Silverman | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| The Honorable Greg Stanton | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
2014 · 26 people listed · 14 paid, $6.9M · 349 employees · 85 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Jeffrey M Trent PhD | BOARD MEMBER/PRES/SCIENCE DIR. | 39 | $1,295,334 | $0 | $120,337 | $1,415,671 | 4 |
| Teresa Burleson | Chief Operating Officer | 39 | $764,367 | $0 | $67,475 | $831,842 | 2 |
| DANIEL VON HOFF | EXECUTIVE VICE PRESIDENT | 40 | $686,403 | $0 | $66,888 | $753,291 | 1 |
| Patrick Smith | VP, Corporate Development | 40 | $624,185 | $0 | $8,942 | $633,127 | 1 |
| David Craig | Deputy Director of Informatics | 40 | $512,177 | $0 | $70,049 | $582,226 | 2 |
| John Carpten | Deputy Director of Sciences | 40 | $500,526 | $0 | $70,562 | $571,088 | 1 |
| Michael Berens | Deputy Director of Research | 40 | $386,107 | $0 | $19,442 | $405,549 | 2 |
| Stephanie A McRae | General Counsel | 40 | $294,428 | $0 | $18,063 | $312,491 | 1 |
| Charles K Coleson | Chief Financial Officer | 29 | $264,145 | $0 | $18,448 | $282,593 | 2 |
| David Duggan | Associate Professor | 40 | $227,415 | $0 | $21,853 | $249,268 | 1 |
| Johanna Distefano | Professor | 40 | $233,725 | $0 | $10,077 | $243,802 | 1 |
| Manuel Estrada | Vice President, Finance | 40 | $220,702 | $0 | $14,143 | $234,845 | 2 |
| James Lowey | Vice President, Technology | 40 | $201,561 | $0 | $9,405 | $210,966 | 1 |
| James Harris | Vice President, Business Dev. | 0 | $182,330 | $0 | $16,524 | $198,854 | 1 |
| RICHARD L BOALS | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| GOVERNOR JAN BREWER | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert Bulla | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Bennett Dorrance | Board Member/Secretary | 1 | $0 | $0 | $0 | $0 | 3 |
| PETER S FINE | BOARD MEMBER (THRU 2/14) | 1 | $0 | $0 | $0 | $0 | 1 |
| Bert Getz | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| David J Gullen MD | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Jeffrey Moorad | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Cindy Parseghian | Board Member/Treasurer | 1 | $0 | $0 | $0 | $0 | 1 |
| William J Post | Board Member/Chairman | 1 | $0 | $0 | $0 | $0 | 7 |
| Richard Silverman | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| The Honorable Greg Stanton | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
2013 · 33 people listed · 18 paid, $6.5M · 362 employees · 70 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Jeffrey M Trent PhD | Board Member/Pres/Science Dir. | 39 | $877,215 | $0 | $117,686 | $994,901 | 4 |
| Daniel Von Hoff | Executive Vice President | 40 | $666,497 | $0 | $64,858 | $731,355 | 1 |
| Spyro Mousses | Vice President | 40 | $569,124 | $0 | $19,322 | $588,446 | 1 |
| Teresa Burleson | Chief Operating Officer | 39 | $451,701 | $0 | $66,559 | $518,260 | 2 |
| John Carpten | Deputy Director of Sciences | 40 | $385,415 | $0 | $69,571 | $454,986 | 1 |
| Michael Berens | Deputy Director of Research | 40 | $394,169 | $0 | $17,918 | $412,087 | 2 |
| David Craig | Deputy Director of Informatics | 40 | $332,802 | $0 | $69,056 | $401,858 | 2 |
| Elizabeth Montemayor | CFO (THRU 03/15/13) | 39 | $273,937 | $0 | $5,347 | $279,284 | 2 |
| Patrick Smith | VP, Corporate Development | 40 | $265,033 | $0 | $6,947 | $271,980 | 1 |
| Stephanie A McRae | General Counsel | 40 | $238,299 | $0 | $17,591 | $255,890 | 1 |
| Johanna Distefano | Professor | 40 | $222,662 | $0 | $11,960 | $234,622 | 1 |
| David Duggan | Associate Professor | 40 | $212,524 | $0 | $19,403 | $231,927 | 1 |
| Michael Bittner | Professor | 40 | $203,321 | $0 | $15,137 | $218,458 | 1 |
| James Harris | Vice President, Business Dev. | 40 | $194,816 | $0 | $16,103 | $210,919 | 1 |
| Galen Perry | VP, Marketing & Communications | 40 | $185,860 | $0 | $16,763 | $202,623 | 1 |
| James Lowey | Vice President, Technology | 40 | $176,511 | $0 | $7,306 | $183,817 | 1 |
| Edward Suh | Chief Information Officer | 0 | $139,307 | $0 | $0 | $139,307 | 1 |
| Charles K Coleson | CFO (FROM 05/28/13) | 29 | $124,189 | $0 | $8,792 | $132,981 | 2 |
| Jerry Bisgrove | Board Member (PART YEAR) | 1 | $0 | $0 | $0 | $0 | 2 |
| Richard L Boals | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Governor Jan Brewer | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert Bulla | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Jose Cardenas | Board Member (PART YEAR) | 1 | $0 | $0 | $0 | $0 | 3 |
| Bennett Dorrance | Board Member/Secretary | 1 | $0 | $0 | $0 | $0 | 3 |
| Peter S Fine | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Bert Getz | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| David J Gullen MD | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| Jeffrey Moorad | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| T Lon Owen PhD | Board Member (PART YEAR) | 1 | $0 | $0 | $0 | $0 | 1 |
| Cindy Parseghian | Board Member/Treasurer | 1 | $0 | $0 | $0 | $0 | 1 |
| William J Post | Board Member/Chairman | 1 | $0 | $0 | $0 | $0 | 7 |
| Richard Silverman | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
| The Honorable Greg Stanton | Board Member | 1 | $0 | $0 | $0 | $0 | 1 |
2011 · 32 people listed · 16 paid, $6.2M · 402 employees · 60 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| JEFFREY TRENT | BM / PRES / SCIENCE DIRECTOR | 39 | - | $1,085,392 | $455,479 | $1,540,871 | 4 |
| DANIEL VON HOFF | EXECUTIVE VICE PRESIDENT | 40 | $684,393 | $0 | $15,717 | $700,110 | 1 |
| TERESA BURLESON | CHIEF OPERATING OFFICER | 39 | $440,722 | $0 | $16,059 | $456,781 | 2 |
| MICHAEL BERENS | DEPUTY DIRECTOR OF RESEARCH | 40 | $316,743 | $0 | $16,630 | $333,373 | 2 |
| SPYRO MOUSSES | VICE PRESIDENT | 40 | $305,359 | $0 | $18,455 | $323,814 | 1 |
| JEFFREY NIEVES | DEPUTY DIRECTOR (THRU 11/2011) | 40 | $297,766 | $0 | $13,163 | $310,929 | 1 |
| JOHN CARPTEN | DEPUTY DIRECTOR OF SCIENCES | 40 | $242,137 | $0 | $60,462 | $302,599 | 1 |
| STEPHANIE MCRAE | GENERAL COUNSEL | 40 | $283,646 | $0 | $10,442 | $294,088 | 1 |
| EDWARD SUH | CHIEF INFORMATION OFFICER | 40 | $275,250 | $0 | $18,118 | $293,368 | 1 |
| DAVID DUGGAN | ASSOCIATE PROFESSOR | 40 | $258,844 | $0 | $20,488 | $279,332 | 1 |
| ELIZABETH MONTEMAYOR | CHIEF FINANCIAL OFFICER | 40 | $244,212 | $0 | $20,350 | $264,562 | 2 |
| STEPHEN GATELY | TD2 PRESIDENT / SCIENTIFIC DIR | 40 | $247,019 | $0 | $5,667 | $252,686 | 1 |
| JOHANNA DISTEFANO | PROFESSOR | 40 | $224,193 | $0 | $11,867 | $236,060 | 1 |
| JAMES HARRIS | VP BUSINESS DEVELOPMENT | 40 | $209,984 | $0 | $21,657 | $231,641 | 1 |
| GALEN PERRY | VP MARKETING/COMMUNICATIONS | 40 | $200,680 | - | $16,871 | $217,551 | 1 |
| DAVID CRAIG | DEPUTY DIRECTOR INFO SCIENCES | 40 | $157,812 | - | $54,159 | $211,971 | 2 |
| JERRY BISGROVE | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 2 |
| GOVERNOR JAN BREWER | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT BULLA | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| JOSE CARDENAS | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 3 |
| BENNETT DORRANCE | BOARD MEMBER / SECRETARY | 1 | $0 | $0 | $0 | $0 | 3 |
| PETER S FINE | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| BERT GETZ | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID GULLEN MD | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| JEFFREY MOORAD | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| T LON OWEN PHD | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| CINDY PARSEGHIAN | BOARD MEMBER / TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM J POST | BOARD MEMBER / CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 7 |
| RICHARD SILVERMAN | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| THE HONORABLE GREG STANTON | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN KENNEDY | BOARD MEMBER (THRU 3/2012) | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID VAN ANDEL | BOARD MEMBER (THRU 3/2012) | 1 | $0 | $0 | $0 | $0 | 5 |
2010 · 28 people listed · 14 paid, $5.6M · 402 employees · 49 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| JEFFREY TRENT | BOARD MEMBER/PRES & SCIEN DIR | 14 | $0 | $1,043,405 | $303,030 | $1,346,435 | 4 |
| DANIEL VON HOFF | EXECUTIVE VICE PRESIDENT | 40 | $638,624 | $0 | $26,714 | $665,338 | 1 |
| TESS BURLESON | CHIEF OPERATING OFFICER | 39 | $438,463 | $0 | $21,555 | $460,018 | 2 |
| JOHN CARPTEN | PROFESSOR | 40 | $320,177 | $0 | $23,623 | $343,800 | 1 |
| MICHAEL BERENS | PROFESSOR | 40 | $294,211 | $0 | $44,202 | $338,413 | 2 |
| EDWARD SUH | CHIEF INFORMATION OFFICER | 40 | $279,758 | $0 | $45,633 | $325,391 | 1 |
| SPYRO MOUSSES | VICE PRESIDENT | 40 | $284,643 | $0 | $20,778 | $305,421 | 1 |
| STEPHANIE MCRAE | GENERAL COUNSEL | 40 | $265,550 | $0 | $33,132 | $298,682 | 1 |
| DAVID DUGGAN | ASSOCIATE PROFESSOR | 40 | $266,184 | $0 | $27,770 | $293,954 | 1 |
| ELIZABETH MONTEMAYOR | CHIEF FINANCIAL OFFICER | 40 | $265,904 | $0 | $26,388 | $292,292 | 2 |
| JAMES HARRIS | VP BUSINESS DEVELOPMENT | 40 | $216,461 | $0 | $6,716 | $223,177 | 1 |
| STEPHEN GATELY | TD2 PRESIDENT/SCIENTIFIC DIR. | 40 | $218,087 | $0 | $4,716 | $222,803 | 1 |
| STEVE DAY | DIRECTOR, SOFTWARE ENGINEERING | 40 | $212,332 | $0 | $6,772 | $219,104 | 1 |
| JANINE TILLI | VICE PRESIDENT, HUMAN RESOURCE | 40 | $206,499 | $0 | $8,963 | $215,462 | 1 |
| GOVERNER JAN BREWER | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT BULLA | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| JOSE CARDENAS | BOARD MEMBER / CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 3 |
| BENNETT DORRANCE | BOARD MEMBER / SECRETARY | 1 | $0 | $0 | $0 | $0 | 3 |
| PETER S FINE | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID GULLEN MD | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN KENNEDY | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| JEFFREY MOORAD | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| T LON OWEN PHD | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| CINDY PARSEGHIAN | BOARD MEMBER / TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM J POST | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 7 |
| RICHARD SILVERMAN | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| THE HONORABLE GREG STANTON | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID VAN ANDEL | BOARD MEMBER | 1 | $0 | $0 | $0 | $0 | 5 |
2009 · 36 people listed · 10 paid, $4.3M · 407 employees · 65 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| JEFFREY M TRENT PHD | PRESIDENT/DIRECTOR | 40 | $1,046,046 | $0 | $17,553 | $1,063,599 | 4 |
| DANIEL VON HOFF | EXECUTIVE VICE PRESIDENT | 40 | $946,876 | $0 | $13,803 | $960,679 | 1 |
| TERESA BURLESON | CHIEF OPERATING OFFICER | 40 | $375,130 | $0 | $14,061 | $389,191 | 2 |
| JAMES HARRIS | VP BUSINESS DEVELOPMENT | 40 | $305,556 | $0 | $13,968 | $319,524 | 1 |
| EDWARD SUH | CHIEF INFORMATION OFFICER | 40 | $299,023 | $0 | $15,791 | $314,814 | 1 |
| MICHAEL BERENS | PROFESSOR | 40 | $291,892 | $0 | $15,718 | $307,610 | 2 |
| JOHN CARPTEN | SENIOR INVESTIGATOR | 40 | $274,805 | $0 | $13,724 | $288,529 | 1 |
| SPYRO MOUSSES | SENIOR INVESTIGATOR | 40 | $249,797 | $0 | $15,438 | $265,235 | 1 |
| ELIZABETH MONTEMAYOR | CFO/ASSIST TREASURER | 40 | $230,161 | $0 | $15,022 | $245,183 | 2 |
| MARY ANNE GUERRA | PRESIDENT, TGEN ACCELERATORS | 40 | $112,918 | $0 | $6,625 | $119,543 | 1 |
| GOVERNOR JAN BREWER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JOSE CARDENAS | DIRECTOR/CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 3 |
| BENNETT DORRANCE | DIRECTOR/SECRETARY | 1 | $0 | $0 | $0 | $0 | 3 |
| ROBERT BULLA | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER S FINE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JEFFREY MOORAD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| HONORABLE PHIL GORDON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| T LON OWEN PHD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| CINDY PARSEGHIAN | DIRECTOR/TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM J POST | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 7 |
| DAVID J GULLEN MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD SILVERMAN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN KENNEDY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID VAN ANDEL | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| BETSEY BAYLESS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| R RICHARD L BOALS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| SUSAN CLARK JOHNSON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL CROW PHD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 11 |
| HONORABLE DIANE ENOS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| BERT A GETZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN D HAEGER PHD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN MURPHY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| KEITH R MCKENNON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| FRANKLYN G PRENDERGAST MD PHD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT N SHELTON PHD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| HONORABLE JIM SLATTERY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
Highest-paid independent contractors
2024 · 5 contractors · $1.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| ERNST & YOUNG US LLP | SECAUCUS, NJ | PROFESSIONAL SERVICES | $317,237 |
| FIRSTSTRATEGIC LLC | PHOENIX, AZ | CONSULTING SERVICES | $216,000 |
| IT CONVERGENCE | REDWOOD CITY, CA | CONSULTING SERVICES | $181,784 |
| GIRIKON | PHOENIX, AZ | CONSULTING SERVICES | $175,568 |
| PROTOS SOFTWARE LLC | MESA, AZ | CONSULTING SERVICES | $174,623 |
2023 · 4 contractors · $788K
| Name | Location | Service | Paid |
|---|---|---|---|
| ERNST & YOUNG US LLP | Secaucus, NJ | PROFESSIONAL SERVICES | $239,916 |
| FIRSTSTRATEGIC LLC | PHOENIX, AZ | CONSULTING SERVICES | $216,000 |
| PROTOS SOFTWARE LLC | TEMPE, AZ | CONSULTING SERVICES | $193,058 |
| THREE DIMENSIONAL RESOURCE PLANNING LLC | SCOTTSDALE, AZ | CONSULTING SERVICES | $139,423 |
2022 · 4 contractors · $803K
| Name | Location | Service | Paid |
|---|---|---|---|
| ERNST & YOUNG US LLP | Secaucus, NJ | PROFESSIONAL SERVICES | $342,730 |
| FIRSTSTRATEGIC | PHOENIX, AZ | CONSULTING SERVICES | $216,000 |
| IAA CONSULTING LLC | SKILLMAN, NJ | CONSULTING SERVICES | $124,575 |
| MUHAMMED MURTAZA | MIDDLETON, WI | PROFESSIONAL SERVICES | $120,000 |
2021 · 5 contractors · $1.5M
| Name | Location | Service | Paid |
|---|---|---|---|
| GIRIKON LLC | PHOENIX, AZ | CONSULTING SERVICES | $654,715 |
| PRICEWATERHOUSECOOPERS LLP | LOS ANGELES, CA | CONSULTING SERVICES | $245,000 |
| FIRSTSTRATEGIC | PHOENIX, AZ | CONSULTING SERVICES | $216,000 |
| ERNST & YOUNG LLP | LOS ANGELES, CA | PROFESSIONAL SERVICES | $190,000 |
| MUHAMMED MURTAZA | MIDDLETON, WI | PROFESSIONAL SERVICES | $150,000 |
2020 · 5 contractors · $1.4M
| Name | Location | Service | Paid |
|---|---|---|---|
| GIRIKON LLC | PHOENIX, AZ | CONSULTING SERVICES | $332,807 |
| IMAGING ENDPOINTS II LLC | SCOTTSDALE, AZ | CONSULTING SERVICES | $304,327 |
| ERNST YOUNG LLP | LOS ANGELES, CA | PROF. SERVICES | $271,615 |
| BOOTH UDALL FULLER PLC | TEMPE, AZ | LEGAL SERVICES | $250,482 |
| FIRSTSTRATEGIC | PHOENIX, AZ | CONSULTING SERVICES | $198,000 |
2019 · 5 contractors · $961K
| Name | Location | Service | Paid |
|---|---|---|---|
| Girikon LLC | PHOENIX, AZ | CONSULTING SERVICES | $249,876 |
| BOOTH UDALL FULLER PLC | TEMPE, AZ | LEGAL SERVICES | $225,938 |
| FIRSTSTRATEGIC | PHOENIX, AZ | CONSULTING SERVICES | $216,000 |
| TECH66 LLC | PHOENIX, AZ | CONSULTING SERVICES | $157,842 |
| ASG GROUP LLC | SOUTHBURY, CT | CONSULTING SERVICES | $111,000 |
2018 · 5 contractors · $6.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| Ashion Analytics LLC | Phoenix, AZ | Laboratory services | $5,134,987 |
| PriceWaterhouseCoopers LLP | Los Angeles, CA | Legal services | $272,142 |
| Booth Udall PLC | Tempe, AZ | Legal services | $243,469 |
| FirstStrategic | Phoenix, AZ | Consulting services | $216,580 |
| ASG Group LLC | Southbury, CT | Consulting services | $168,000 |
2017 · 5 contractors · $7.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| ASHION ANALYTICS LLC | Phoenix, AZ | LABORATORY SERVICES | $5,957,000 |
| ERNST YOUNG LLP | SECAUCUS, NJ | ACCOUNTING SERVICES | $548,011 |
| TRANSLATIONAL DRUG DEVELOPMENT | SCOTTSDALE, AZ | CONSULTING SERVICES | $257,913 |
| ASG GROUP LLC | SOUTHBURY, CT | CONSULTING SERVICES | $225,000 |
| FIRSTSTRATEGIC | PHOENIX, AZ | CONSULTING SERVICES | $216,000 |
2016 · 5 contractors · $3.4M
| Name | Location | Service | Paid |
|---|---|---|---|
| ASHION ANALYTICS | PHOENIX, AZ | LABORATORY SERVICES | $2,714,832 |
| ERNST YOUNG LLP | SECAUCUS, NJ | ACCOUNTING SERVICES | $320,143 |
| ASG GROUP LLC | SOUTHBURY, CT | CONSULTING SERVICES | $143,082 |
| TRANSLATIONAL DRUG DEVELOPMENT LLC | SCOTTSDALE, AZ | CONSULTING SERVICES | $130,417 |
| FIRST STRATEGIC | PHOENIX, OR | Consulting Services | $128,350 |
2015 · 3 contractors · $536K
| Name | Location | Service | Paid |
|---|---|---|---|
| FirstStrategic | Phoenix, AZ | Consulting Services | $216,000 |
| Cancer Research and Biostatistics | Seattle, WA | Research Services | $203,839 |
| Tech66 LLC | Phoenix, AZ | Consulting Services | $115,950 |
2014 · 4 contractors · $671K
| Name | Location | Service | Paid |
|---|---|---|---|
| FIRSTSTRATEGIC | PHOENIX, AZ | CONSULTING SERVICES | $198,000 |
| CANCER RESEARCH AND BIOSTATISTICS | SEATTLE, WA | RESEARCH SERVICES | $190,821 |
| TECH66 LLC | PHOENIX, AZ | CONSULTING SERVICES | $181,625 |
| POLSINELLI PC | KANSAS CITY, MO | LEGAL SERVICES | $100,990 |
2013 · 5 contractors · $906K
| Name | Location | Service | Paid |
|---|---|---|---|
| Cancer Research and Biostatistics | Research Services | $212,751 | |
| Polsinelli | Legal Services | $180,715 | |
| FirstStrategic | Consulting Services | $180,000 | |
| TECH66 LLC | Consulting Services | $176,314 | |
| Lockton Companies | insurance broker | $156,240 |
2011 · 5 contractors · $1.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| PERSISTENT SYSTEMS LTD | PUNE, PUNE | SOFTWARE DEVELOPMENT | $289,643 |
| JULIE BERNARD | LAFAYETTE, CO | LEGAL SERVICES | $226,621 |
| ERNST YOUNG LLP | LOS ANGELES, CA | AUDIT SERVICES | $204,401 |
| PRICEWATERHOUSECOOPERS LLP | LOS ANGELES, CA | CONSULTING SERVICES | $199,250 |
| FIRSTSTRATEGIC | PHOENIX, AZ | CONSULTING SERVICES | $184,877 |
2010 · 5 contractors · $1.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| ERNST YOUNG LLP | LOS ANGELES, CA | AUDIT SERVICES | $413,664 |
| 5AM SOLUTIONS | PHOENIX, AZ | IT SUPPORT SERVICES | $377,421 |
| AON RISK SERVICES | CHICAGO, IL | INSURANCE BROKER | $359,105 |
| JULIE BERNARD | LAFAYETTE, CO | LEGAL SERVICES | $221,421 |
| PRICEWATERHOUSECOOPERS | LOS ANGELES, CA | CONSULTING SERVICES | $199,250 |
2009 · 5 contractors · $3.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| JOKAKE CONSTRUCTION SERVICES INC | PHOENIX, AZ | CONSTRUCTION SVCS | $1,975,490 |
| QUARLES BRADY STREICH LANG | PHOENIX, AZ | LEGAL SERVICES | $399,584 |
| WILLIS OF ARIZONA | PHOENIX, AZ | INSURANCE BROKER | $362,380 |
| ERNST YOUNG LLP | LOS ANGELES, CA | AUDIT SERVICES | $288,283 |
| 5AM SOLUTIONS | PHOENIX, AZ | LEGAL SERVICES | $165,531 |
Who the money went to
Grants this organization reported paying: Schedule I Part II of the Form 990, or the grants-paid list on the 990-PF. Open a year for every recipient. Recipients link to their own page when the grant names an EIN we have (990-PF grants list no EIN, so those link only on an exact, unique name and state). Grants to individuals are counted; their names are not shown.
2022 · 1 grant to organizations · $1.8M
2021 · 1 grant to organizations · $328K
Negative amounts are returned or refunded grants; they are listed last and left out of the totals of grants paid.
Who gave
Contributor names are not public for this form type.
Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.
Finances
Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.
| Revenue | Expenses | Assets | Net assets | Contributions | Program revenue | Officer pay | Employees | Volunteers |
|---|---|---|---|---|---|---|---|---|
| 2024 · Form 990 | ||||||||
| $75,913,310 | $86,279,860 | $136,062,120 | $85,984,729 | $42,119,398 | $35,204,897 | $5,040,939 | 406 | 70 |
| 2023 · Form 990 | ||||||||
| $85,916,307 | $84,441,597 | $148,610,558 | $95,626,678 | $36,551,884 | $40,602,807 | $5,070,553 | 463 | 52 |
| 2022 · Form 990 | ||||||||
| $49,618,841 | $81,144,473 | $145,155,331 | $90,428,891 | $40,082,268 | $11,607,330 | $5,279,740 | 496 | 50 |
| 2021 · Form 990 | ||||||||
| $47,789,496 | $74,504,945 | $174,203,210 | $116,968,974 | $33,269,986 | $14,701,502 | $5,065,632 | 450 | 42 |
| 2020 · Form 990 | ||||||||
| $175,687,790 | $99,192,595 | $224,233,974 | $154,529,936 | $36,277,806 | $25,808,862 | $4,023,188 | 469 | 48 |
| 2019 · Form 990 | ||||||||
| $74,149,393 | $78,803,060 | $140,363,431 | $77,890,049 | $54,124,639 | $23,939,255 | $4,843,763 | 419 | 62 |
| 2018 · Form 990 | ||||||||
| $77,428,548 | $64,872,822 | $140,891,715 | $82,408,786 | $62,343,578 | $17,942,426 | $3,939,371 | 354 | 70 |
| 2017 · Form 990 | ||||||||
| $57,643,920 | $57,255,533 | $136,019,915 | $69,837,036 | $31,879,587 | $22,244,021 | $3,774,089 | 298 | 62 |
| 2016 · Form 990 | ||||||||
| $89,801,983 | $44,361,873 | $96,504,823 | $80,113,416 | $67,494,504 | $21,488,428 | $3,245,093 | 326 | 68 |
| 2015 · Form 990 | ||||||||
| $40,249,979 | $50,318,005 | $42,113,953 | $24,029,243 | $21,230,401 | $16,538,667 | $4,780,495 | 345 | 70 |
| 2014 · Form 990 | ||||||||
| $84,245,566 | $56,395,883 | $78,134,333 | $58,284,158 | $15,937,701 | $17,307,268 | $4,610,620 | 349 | 85 |
| 2013 · Form 990 | ||||||||
| $66,522,852 | $57,794,435 | $48,515,458 | $32,413,623 | $25,261,567 | $23,328,457 | $5,913,383 | 362 | 70 |
| 2011 · Form 990 | ||||||||
| $48,492,051 | $57,632,572 | $42,514,714 | $24,316,530 | $27,781,232 | $19,840,214 | $4,087,276 | 402 | 60 |
| 2010 · Form 990 | ||||||||
| $60,822,104 | $73,173,514 | $50,603,221 | $32,798,118 | $39,499,881 | $20,855,027 | $3,906,893 | 402 | 49 |
| 2009 · Form 990 | ||||||||
| $72,403,389 | $67,133,632 | $68,826,227 | $44,571,944 | $50,530,395 | $21,824,292 | $4,132,204 | 407 | 65 |
Connected to
Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.
- CITY OF HOPE Duarte, CA · 7 people in common (Anthony Scott, Cristin Ocallahan, Jennifer Parkhurst) · related organization (Schedule R)
- CITY OF HOPE NATIONAL MEDICAL CENTER Duarte, CA · 5 people in common (Cristin Ocallahan, Jeffrey M Trent Phd, Jennifer Parkhurst) · related organization (Schedule R)
- WESTERN REGIONAL MEDICAL CENTER LLC Duarte, CA · 5 people in common (Cristin Ocallahan, Jennifer Parkhurst, Robert W Stone) · related organization (Schedule R)
- MIDWESTERN REGIONAL MEDICAL CENTER INC Duarte, CA · 5 people in common (Cristin Ocallahan, Jennifer Parkhurst, Robert W Stone) · related organization (Schedule R)
- SOUTHEASTERN REGIONAL MEDICAL CENTER LLC Duarte, CA · 5 people in common (Cristin Ocallahan, Jennifer Parkhurst, Robert W Stone) · related organization (Schedule R)
- COH HOLDCO INC Duarte, CA · 5 people in common (Cristin Ocallahan, Jennifer Parkhurst, Robert W Stone) · related organization (Schedule R)
- TRANSLATIONAL GENOMICS RESEARCH INSTITUTE FOUNDATION Phoenix, AZ · 5 people in common (Bennett Dorrance, Jeffrey M Trent Phd, Manuel Estrada) · related organization (Schedule R)
- CITY OF HOPE MEDICAL FOUNDATION Duarte, CA · 4 people in common (Cristin Ocallahan, Jennifer Parkhurst, Robert W Stone)
- BECKMAN RESEARCH INSTITUTE Duarte, CA · 4 people in common (Cristin Ocallahan, Jennifer Parkhurst, Robert W Stone) · related organization (Schedule R)
- GREATER PHOENIX ECONOMIC COUNCIL Phoenix, AZ · 2 people in common (Bennett Dorrance, Sharon Harper)
- ARIZONA TECHNOLOGY COUNCIL Phoenix, AZ · 2 people in common (Kevin Campbell, Michael Berens)
- CREIGHTON UNIVERSITY Omaha, NE · 1 person in common (Sharon Harper)
- BLOOD CANCER UNITED INC Washington, DC · 1 person in common (Yvette Tremonti)
- VAN ANDEL RESEARCH INSTITUTE Grand Rapids, MI · 1 person in common (Jeffrey M Trent Phd)
- NATIONAL COMPREHENSIVE CANCER NETWORK INC Plymouth Mtng, PA · 1 person in common (Yvette Tremonti)
- BANNER HEALTH FOUNDATION Phoenix, AZ · 1 person in common (Sharon Harper)
- GREATER PHOENIX LEADERSHIP INC Phoenix, AZ · 1 person in common (Sharon Harper)
- ALLIANCE OF DEDICATED CANCER CENTERS INC Houston, TX · 1 person in common (Yvette Tremonti)
Funders of this organization
74 grantors reported grants to this organization, $297,216,396 in all, tax years 2009 to 2025; the 25 largest shown (all 74). Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV
| Grantor | Total given | Grants | Latest year's amount | Latest year | Years given | Type | Match | Grants |
|---|---|---|---|---|---|---|---|---|
| CITY OF HOPE | $131,839,796 | 9 | $60,447 | 2024 | 2016-2024 | Public charity | Exact | show |
| TRANSLATIONAL GENOMICS RESEARCH INSTITUTE FOUNDATION | $122,389,229 | 15 | $7,267,203 | 2024 | 2009-2011, 2013-2024 | Public charity | Exact | show |
| FRED HUTCHINSON CANCER RESEARCH CENTER | $9,959,596 | 20 | $231,101 | 2013 | 2009-2013 | Public charity | Exact | show |
| THE NARBHA INSTITUTE | $2,670,000 | 5 | $520,000 | 2022 | 2018-2022 | Public charity | Exact | show |
| VIRGINIA G PIPER CHARITABLE TRUST 08-11-95 | $2,607,500 | 4 | $500,000 | 2024 | 2019, 2021-2022, 2024 | Private foundation | Fuzzy filed as “The Translational Genomics Research Institute (TGen)” | show |
| MAYO CLINIC | $2,184,128 | 4 | $832,905 | 2013 | 2010-2013 | Public charity | Exact | show |
| CANCER RESEARCH AMERICA NFCR INC | $2,034,223 | 11 | $101,587 | 2019 | 2010, 2012-2019 | DAF sponsor | Exact | show |
| CITY OF HOPE NATIONAL MEDICAL CENTER | $1,715,150 | 3 | $611,088 | 2023 | 2019, 2021, 2023 | Public charity | Exact | show |
| BECKMAN RESEARCH INSTITUTE | $1,696,136 | 2 | $1,633,728 | 2023 | 2019, 2023 | Public charity | Exact | show |
| YALE UNIVERSITY | $1,642,415 | 8 | $270,495 | 2024 | 2015, 2018-2024 | DAF sponsor | Exact | show |
| NORTHWESTERN UNIVERSITY | $1,639,719 | 5 | $228,422 | 2024 | 2020-2024 | DAF sponsor | Exact | show |
| TRUSTEES OF COLUMBIA UNIVERSITY | $1,456,114 | 12 | $8,999 | 2024 | 2009-2018, 2023-2024 | DAF sponsor | Exact | show |
| JOHN TEMPLETON FOUNDATION | $1,323,116 | 4 | $695,274 | 2024 | 2022-2024 | Private foundation | Fuzzy filed as “THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE”, “TRANSLATIONAL GENOMICS RESEARCH INSTITUTE” | show |
| UNIVERSITY OF CHICAGO | $1,164,433 | 2 | $1,076,771 | 2024 | 2015, 2024 | Public charity | Exact | show |
| VANDERBILT UNIVERSITY MEDICAL CENTER | $987,749 | 7 | $367,188 | 2024 | 2018-2024 | Public charity | Exact | show |
| MAYO CLINIC GROUP RETURN | $880,732 | 8 | $23,977 | 2024 | 2017-2024 | Public charity | Exact | show |
| UNIVERSITY OF MIAMI | $785,943 | 6 | $5,612 | 2018 | 2013-2018 | Public charity | Exact | show |
| MICHAEL J FOX FOUNDATION FOR PARKINSONS RESEARCH | $741,885 | 8 | $7,964 | 2020 | 2010, 2013-2016, 2019-2020 | Public charity | Exact | show |
| CRITICAL PATH INSTITUTE | $723,538 | 3 | $35,000 | 2019 | 2017-2019 | Public charity | Exact | show |
| SILICON VALLEY COMMUNITY FOUNDATION | $683,239 | 2 | $500,000 | 2022 | 2017, 2022 | DAF sponsor | Exact | show |
| TRUSTEES OF TUFTS COLLEGE | $677,984 | 5 | $219,657 | 2021 | 2017-2021 | Public charity | Exact | show |
| UNIVERSITY OF PITTSBURGH | $654,927 | 4 | $309,999 | 2024 | 2010-2011, 2023-2024 | Public charity | Exact | show |
| MAYO CLINIC | $648,618 | 8 | $89,027 | 2019 | 2010-2011, 2013-2015, 2017-2019 | DAF sponsor | Exact | show |
| ENTERTAINMENT INDUSTRY FOUNDATION | $518,102 | 1 | $518,102 | 2014 | 2014 | DAF sponsor | Exact | show |
| ANIMAL CANCER FOUNDATION | $510,000 | 1 | $510,000 | 2024 | 2024 | Public charity | Exact | show |
Nearby + Similar BETA
Organizations like this one: what they do and who they are linked to
Same category: NTEE code and revenue
Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. Same state only · More (100)
| Organization | State | NTEE | Latest revenue | Latest expenses | Top-paid title | Top pay | Why similar |
|---|---|---|---|---|---|---|---|
| BAYLOR RESEARCH INSTITUTE | TX | H90 | $89,491,341 | $85,910,172 | Trustee | $2,977,455 | Same NTEE code H90, revenue within 2x |
| HENNEPIN HEALTHCARE RESEARCH INSTITUTE | MN | H90 | $54,717,221 | $53,504,403 | DIRECTOR/PHYSICIAN (UNTIL 6/24) | $660,695 | Same NTEE code H90, revenue within 2x |
| J DAVID GLADSTONE INSTITUTES | CA | H90 | $119,155,911 | $144,808,821 | PRESIDENT | $1,182,258 | Same NTEE code H90, revenue within 2x |
| LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL | CA | H90 | $94,550,669 | $106,850,446 | INTERIM CEO | $925,655 | Same NTEE code H90, revenue within 2x |
| THE MEDICAL UNIVERSITY OF SOUTH CAROLINA FOUNDATION | SC | H90 | $136,664,063 | $81,004,152 | CHIEF EXECUTIVE OFFICER | $635,452 | Same NTEE code H90, revenue within 2x |
| THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH | NY | H90 | $163,308,471 | $163,279,325 | EVP & CFO | $1,990,193 | Same NTEE code H90, revenue within 5x |
| VETERANS MEDICAL RESEARCH FOUNDATION OF SD | CA | H90 | $16,030,812 | $16,560,898 | EXECUTIVE DIRECTOR/CEO | $405,278 | Same NTEE code H90, revenue within 5x |
| WILLIAM K WARREN MEDICAL RESEARCH CENTER INC | OK | H90 | $16,183,718 | $1,805,546 | DIRECTOR | $508,503 | Same NTEE code H90, revenue within 5x |
| SPORTS MEDICINE RESEARCH AND TESTING LABORATORY | UT | H90 | $24,588,184 | $16,194,140 | PRESIDENT/LAB DIRECTOR | $622,114 | Same NTEE code H90, revenue within 5x |
| MONELL CHEMICAL SENSES CENTER | PA | H90 | $20,726,758 | $20,366,058 | Exec Dir President | $360,927 | Same NTEE code H90, revenue within 5x |
| WICELL RESEARCH INSTITUTE INC | WI | H90 | $8,652,497 | $9,081,897 | CHIEF EXECUTIVE OFFICER | $395,711 | Same NTEE code H90, revenue within 10x |
| TRUDEAU INSTITUTE INC | NY | H90 | $8,214,270 | $10,300,898 | PRESIDENT AND DIRECTOR | $220,400 | Same NTEE code H90, revenue within 10x |
| ESSENTIA INSTITUTE OF RURAL HEALTH | MN | H90 | $10,547,026 | $12,202,333 | BOARD CHAIR/RELATED ORG PHYSICIAN | $932,372 | Same NTEE code H90, revenue within 10x |
| REGENSTRIEF FOUNDATION INC | IN | H90 | $14,893,999 | $11,220,711 | PRESIDENT & DIRECTOR | $221,759 | Same NTEE code H90, revenue within 10x |
| ANATOMIC GIFT FOUNDATION INC | MD | H90 | $8,290,549 | $8,031,405 | TREASURER | $232,513 | Same NTEE code H90, revenue within 10x |
| DONALD GUTHRIE FOUNDATION | PA | H90 | $7,763,432 | $3,890,417 | DIRECTOR - PRESIDENT/CEO TGC | $1,895,232 | Same NTEE code H90, revenue within 10x |
| MUSCULOSKELETAL ORTHOPEDIC RESEARCH AND EDUCATION FOUNDATION | AZ | H90 | $464,455 | $804,030 | EXECUTIVE DIRECTOR | $0 | Same NTEE code H90, revenue differs more than 10x, same state |
| STEM CITY | AZ | H90 | $54,165 | $38,391 | TREASURER | $0 | Same NTEE code H90, revenue differs more than 10x, same state |
| CACTIS FOUNDATION | AZ | H90 | $59,568 | $46,138 | Chairman | $0 | Same NTEE code H90, revenue differs more than 10x, same state |
| COGNITIVE RESEARCH ENTERPRISES INC | WV | H90 | $300 | $66,838 | CHAIRMAN DIRECTOR | $0 | Same NTEE code H90, revenue differs more than 10x, similar mission |
| SUTTER BAY MEDICAL FOUNDATION | CA | H90 | $4,059,293,628 | $3,991,034,409 | SH SVP, COO/Asst Sec SBMF | $3,655,805 | Same NTEE code H90, revenue differs more than 10x, similar mission |
| JIS RESEARCH INSTITUTE | OH | H90 | $237,422 | $566,088 | Chairman | $0 | Same NTEE code H90, revenue differs more than 10x, similar name |
| INSTITUTE FOR INJURY RESEARCH | MI | H90 | $33,176 | $28,801 | VICE PRESIDENT | $0 | Same NTEE code H90, revenue differs more than 10x |
| CHICAGO ELECTRICAL TRAUMA RESEARCH INSTITUTE | IL | H90 | $81,495 | $93,053 | Chairman of the Board of Directors | $0 | Same NTEE code H90, revenue differs more than 10x |
| PHARMACEUTICAL EDUCATION & RESEARCH INSTITUTE INC | VA | H90 | $725,464 | $659,678 | Operating Manager | $97,810 | Same NTEE code H90, revenue differs more than 10x |
Who funds organizations like this
Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).
The full list · all similar organizations
Where the money went
Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.
2024 · Form 990 · $86,279,860 spent · pay $45,450,021 · grants $0 · events $326,184
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $32,855,159 | $20,299,513 | $12,555,646 | $0 | 38.1% | |
| Fees: other services | $16,445,752 | $15,109,905 | $1,335,847 | $0 | 19.1% | |
| Office expenses | $10,340,354 | $9,837,279 | $503,075 | $0 | 12.0% | |
| Depreciation and depletion | $7,178,852 | $4,809,831 | $2,369,021 | $0 | 8.3% | |
| Pay: officers, directors, trustees, key employees | $5,040,939 | $2,162,088 | $2,878,851 | $0 | 5.8% | |
| Other employee benefits | $3,211,791 | $1,864,354 | $1,347,437 | $0 | 3.7% | |
| Payroll taxes | $2,652,322 | $1,575,000 | $1,077,322 | $0 | 3.1% | |
| Information technology | $2,413,974 | $1,916,085 | $497,889 | $0 | 2.8% | |
| Pension plan contributions | $1,689,810 | $1,000,000 | $689,810 | $0 | 2.0% | |
| Other (as described) | BAD DEBT EXPENSE | $1,020,942 | $1,020,942 | $0 | $0 | 1.2% |
| Fees: legal | $768,605 | $390,922 | $377,683 | $0 | 0.9% | |
| Occupancy | $687,739 | $226,954 | $460,785 | $0 | 0.8% | |
| Fees: accounting | $409,900 | $8,198 | $401,702 | $0 | 0.5% | |
| Travel | $388,057 | $237,120 | $150,937 | $0 | 0.4% | |
| Conferences, conventions and meetings | $326,184 | $72,967 | $253,217 | $0 | 0.4% | |
| Advertising and promotion | $275,853 | $206,890 | $68,963 | $0 | 0.3% | |
| Other (as described) | DUES AND SUBSCRIPTIONS | $184,717 | $27,999 | $156,718 | $0 | 0.2% |
| Insurance | $129,762 | $28,371 | $101,391 | $0 | 0.2% | |
| Fees: lobbying | $129,600 | $0 | $129,600 | $0 | 0.2% | |
| Other (as described) | RECRUITMENT | $75,636 | $56,727 | $18,909 | $0 | 0.1% |
| Other (as described) | TUITION REIMBURSEMENT | $51,891 | $34,767 | $17,124 | $0 | 0.1% |
| Interest | $2,021 | $1,354 | $667 | $0 | 0.0% | |
| Total | $86,279,860 | 100% |
2023 · Form 990 · $84,441,597 spent · pay $48,134,619 · grants $0 · events $345,971
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Pay: disqualified persons | $34,788,040 | $21,376,837 | $13,411,203 | $0 | 41.2% | |
| Office expenses | $9,679,458 | $9,126,085 | $553,373 | $0 | 11.5% | |
| Fees: other services | $8,996,319 | $7,473,699 | $1,522,620 | $0 | 10.7% | |
| Depreciation and depletion | $8,139,816 | $5,453,677 | $2,686,139 | $0 | 9.6% | |
| Pay: officers, directors, trustees, key employees | $5,070,553 | $2,611,831 | $2,458,722 | - | 6.0% | |
| Information technology | $3,419,028 | $2,749,771 | $669,257 | $0 | 4.0% | |
| Payroll taxes | $3,383,722 | $2,000,000 | $1,383,722 | $0 | 4.0% | |
| Other employee benefits | $3,179,789 | $1,914,309 | $1,265,480 | $0 | 3.8% | |
| Fees: legal | $3,123,974 | $1,561,987 | $1,561,987 | $0 | 3.7% | |
| Pension plan contributions | $1,712,515 | $1,020,000 | $692,515 | $0 | 2.0% | |
| Occupancy | $751,729 | $248,071 | $503,658 | $0 | 0.9% | |
| Fees: accounting | $459,633 | $9,193 | $450,440 | $0 | 0.5% | |
| Travel | $350,953 | $199,929 | $151,024 | $0 | 0.4% | |
| Conferences, conventions and meetings | $345,971 | $99,274 | $246,697 | $0 | 0.4% | |
| Advertising and promotion | $281,501 | $211,126 | $70,375 | $0 | 0.3% | |
| Other (as described) | DUES AND SUBSCRIPTIONS | $168,950 | $29,810 | $139,140 | $0 | 0.2% |
| Insurance | $166,963 | $45,496 | $121,467 | $0 | 0.2% | |
| Fees: lobbying | $129,600 | $0 | $129,600 | $0 | 0.2% | |
| Other (as described) | TUITION REIMBURSEMENT | $95,558 | $64,024 | $31,534 | $0 | 0.1% |
| Interest | $72,943 | $48,872 | $24,071 | $0 | 0.1% | |
| Other (as described) | RECRUITMENT | $59,459 | $44,594 | $14,865 | $0 | 0.1% |
| Other (as described) | BAD DEBT EXPENSE | $59,452 | $59,452 | $0 | $0 | 0.1% |
| All other expenses | $5,671 | $4,253 | $1,418 | $0 | 0.0% | |
| Total | $84,441,597 | 100% |
2022 · Form 990 · $81,144,473 spent · pay $45,831,709 · grants $1,802,912 · events $482,405
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $33,613,240 | $20,017,869 | $13,595,371 | $0 | 41.4% | |
| Office expenses | $9,716,628 | $9,101,499 | $615,129 | $0 | 12.0% | |
| Depreciation and depletion | $7,985,533 | $4,791,320 | $3,194,213 | $0 | 9.8% | |
| Fees: other services | $7,967,658 | $6,134,211 | $1,833,447 | $0 | 9.8% | |
| Pay: officers, directors, trustees, key employees | $5,279,740 | $2,776,696 | $2,503,044 | $0 | 6.5% | |
| Information technology | $3,347,728 | $2,772,056 | $575,672 | $0 | 4.1% | |
| Other employee benefits | $2,674,354 | $1,588,852 | $1,085,502 | $0 | 3.3% | |
| Payroll taxes | $2,604,449 | $1,500,464 | $1,103,985 | $0 | 3.2% | |
| Grants to US organizations and governments | $1,802,912 | $1,802,912 | - | - | 2.2% | |
| Pension plan contributions | $1,659,926 | $973,330 | $686,596 | $0 | 2.0% | |
| Fees: legal | $821,163 | $398,223 | $422,940 | $0 | 1.0% | |
| Advertising and promotion | $742,663 | $556,997 | $185,666 | $0 | 0.9% | |
| Occupancy | $705,016 | $232,655 | $472,361 | $0 | 0.9% | |
| Conferences, conventions and meetings | $482,405 | $85,948 | $396,457 | $0 | 0.6% | |
| Fees: accounting | $452,120 | $9,043 | $443,077 | $0 | 0.6% | |
| Travel | $431,861 | $199,364 | $232,497 | $0 | 0.5% | |
| Interest | $202,204 | $135,477 | $66,727 | $0 | 0.2% | |
| Other (as described) | DUES AND SUBSCRIPTIONS | $173,166 | $38,110 | $135,056 | $0 | 0.2% |
| Insurance | $145,315 | $40,055 | $105,260 | $0 | 0.2% | |
| Fees: lobbying | $129,600 | $0 | $129,600 | $0 | 0.2% | |
| Other (as described) | RECRUITMENT | $97,565 | $73,174 | $24,391 | $0 | 0.1% |
| All other expenses | $45,190 | $0 | $45,190 | $0 | 0.1% | |
| Other (as described) | BAD DEBT EXPENSE | $38,996 | $38,996 | $0 | $0 | 0.0% |
| Other (as described) | RELOCATION | $25,041 | $18,781 | $6,260 | $0 | 0.0% |
| Total | $81,144,473 | 100% |
2021 · Form 990 · $74,504,945 spent · pay $41,065,789 · grants $328,217 · events $388,376
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $30,221,626 | $18,433,749 | $11,787,877 | $0 | 40.6% | |
| Office expenses | $10,793,516 | $10,248,149 | $545,367 | $0 | 14.5% | |
| Fees: other services | $8,108,564 | $6,246,691 | $1,861,873 | $0 | 10.9% | |
| Depreciation and depletion | $6,061,827 | $3,962,768 | $2,099,059 | $0 | 8.1% | |
| Pay: officers, directors, trustees, key employees | $5,065,632 | $2,810,249 | $2,255,383 | $0 | 6.8% | |
| Other employee benefits | $2,731,300 | $1,646,050 | $1,085,250 | $0 | 3.7% | |
| Information technology | $2,574,453 | $2,081,556 | $492,897 | $0 | 3.5% | |
| Payroll taxes | $2,335,576 | $1,410,000 | $925,576 | - | 3.1% | |
| Advertising and promotion | $1,351,196 | $1,013,397 | $337,799 | $0 | 1.8% | |
| Pension plan contributions | $711,655 | $382,493 | $329,162 | $0 | 1.0% | |
| Occupancy | $588,302 | $194,140 | $394,162 | $0 | 0.8% | |
| Fees: legal | $581,550 | $279,144 | $302,406 | $0 | 0.8% | |
| Other (as described) | LOSS ON ASSET ACQUISITION | $500,000 | $0 | $500,000 | $0 | 0.7% |
| Fees: accounting | $470,521 | $9,410 | $461,111 | $0 | 0.6% | |
| Insurance | $389,621 | $88,837 | $300,784 | $0 | 0.5% | |
| Conferences, conventions and meetings | $388,376 | $70,409 | $317,967 | $0 | 0.5% | |
| Grants to US organizations and governments | $328,217 | $328,217 | - | - | 0.4% | |
| Travel | $311,205 | $144,065 | $167,140 | $0 | 0.4% | |
| Other (as described) | RECRUITMENT | $268,344 | $201,258 | $67,086 | - | 0.4% |
| All other expenses | $232,014 | $28,345 | $203,669 | $0 | 0.3% | |
| Other (as described) | RELOCATION | $151,196 | $113,397 | $37,799 | $0 | 0.2% |
| Fees: lobbying | $129,600 | $0 | $129,600 | $0 | 0.2% | |
| Interest | $118,254 | $79,230 | $39,024 | $0 | 0.2% | |
| Other (as described) | BAD DEBT EXPENSE | $92,400 | $92,400 | $0 | $0 | 0.1% |
| Total | $74,504,945 | 100% |
2020 · Form 990 · $99,192,595 spent · pay $40,026,832 · grants $0 · events $211,185
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $30,020,435 | $19,583,609 | $10,436,826 | $0 | 30.3% | |
| Royalties | $16,270,899 | $16,270,899 | - | $0 | 16.4% | |
| Office expenses | $15,851,745 | $15,782,698 | $69,047 | $0 | 16.0% | |
| Fees: other services | $13,083,701 | $11,487,284 | $1,596,417 | $0 | 13.2% | |
| Depreciation and depletion | $7,075,085 | $4,245,051 | $2,830,034 | $0 | 7.1% | |
| Pay: officers, directors, trustees, key employees | $4,023,188 | $1,563,401 | $2,459,787 | $0 | 4.1% | |
| Information technology | $2,900,559 | $1,849,898 | $1,050,661 | $0 | 2.9% | |
| Other employee benefits | $2,718,130 | $1,700,547 | $1,017,583 | $0 | 2.7% | |
| Payroll taxes | $2,278,802 | $1,408,480 | $870,322 | $0 | 2.3% | |
| Pension plan contributions | $986,277 | $614,197 | $372,080 | $0 | 1.0% | |
| Fees: legal | $859,830 | $408,285 | $451,545 | $0 | 0.9% | |
| Fees: accounting | $615,896 | $8,213 | $607,683 | $0 | 0.6% | |
| Advertising and promotion | $580,043 | $433,564 | $146,479 | $0 | 0.6% | |
| Occupancy | $486,255 | $164,772 | $321,483 | $0 | 0.5% | |
| Insurance | $454,554 | $80,766 | $373,788 | $0 | 0.5% | |
| Conferences, conventions and meetings | $211,185 | $52,847 | $158,338 | $0 | 0.2% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $171,104 | $32,133 | $138,971 | $0 | 0.2% |
| Other (as described) | RECRUITMENT | $169,644 | $36,491 | $133,153 | $0 | 0.2% |
| Fees: lobbying | $129,600 | - | $129,600 | $0 | 0.1% | |
| Interest | $114,000 | $181,976 | -$67,976 | $0 | 0.1% | |
| Travel | $99,011 | $37,381 | $61,630 | $0 | 0.1% | |
| Other (as described) | RELOCATION | $72,186 | $5,195 | $66,991 | $0 | 0.1% |
| Other (as described) | ALL OTHER EXPENSES | $20,466 | $31,872 | -$11,406 | $0 | 0.0% |
| Total | $99,192,595 | 100% |
2019 · Form 990 · $78,803,060 spent · pay $37,899,661 · grants $0 · events $248,262
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $27,956,010 | $18,185,934 | $9,770,076 | $0 | 35.5% | |
| Office expenses | $16,056,989 | $15,249,502 | $807,487 | $0 | 20.4% | |
| Fees: other services | $9,390,122 | $7,616,665 | $1,773,457 | $0 | 11.9% | |
| Depreciation and depletion | $7,620,918 | $7,270,173 | $350,745 | $0 | 9.7% | |
| Pay: officers, directors, trustees, key employees | $4,843,763 | $2,187,063 | $2,656,700 | $0 | 6.1% | |
| Information technology | $2,486,905 | $1,748,198 | $738,707 | $0 | 3.2% | |
| Other employee benefits | $2,180,595 | $1,343,468 | $837,127 | $0 | 2.8% | |
| Other (as described) | BAD DEBT EXPENSE | $2,170,915 | $2,161,210 | $9,705 | $0 | 2.8% |
| Payroll taxes | $1,955,273 | $938,605 | $1,016,668 | $0 | 2.5% | |
| Pension plan contributions | $964,020 | $597,856 | $366,164 | $0 | 1.2% | |
| Fees: legal | $486,324 | $3,026 | $483,298 | $0 | 0.6% | |
| Occupancy | $443,357 | $333,387 | $109,970 | $0 | 0.6% | |
| Travel | $398,424 | $206,403 | $192,021 | $0 | 0.5% | |
| Insurance | $361,916 | $65,326 | $296,590 | $0 | 0.5% | |
| Fees: accounting | $294,766 | $10,010 | $284,756 | $0 | 0.4% | |
| Advertising and promotion | $266,575 | $26,971 | $239,604 | $0 | 0.3% | |
| Conferences, conventions and meetings | $248,262 | $143,058 | $105,204 | $0 | 0.3% | |
| Other (as described) | RECRUITMENT | $202,069 | $111,053 | $91,016 | $0 | 0.3% |
| Other (as described) | DUES & SUBSCRIPTION | $149,032 | $45,377 | $103,655 | $0 | 0.2% |
| Interest | $142,476 | $38,861 | $103,615 | $0 | 0.2% | |
| Fees: lobbying | $129,600 | $0 | $129,600 | $0 | 0.2% | |
| Other (as described) | RELOCATION | $31,227 | $87 | $31,140 | $0 | 0.0% |
| All other expenses | $23,522 | - | $23,522 | - | 0.0% | |
| Total | $78,803,060 | 100% |
2018 · Form 990 · $64,872,822 spent · pay $30,375,329 · grants $0 · events $468,557
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $22,251,338 | $15,294,028 | $6,957,310 | $0 | 34.3% | |
| Office expenses | $12,308,256 | $11,710,175 | $598,081 | $0 | 19.0% | |
| Fees: other services | $10,364,129 | $10,125,684 | $238,445 | $0 | 16.0% | |
| Depreciation and depletion | $6,494,360 | $3,833,130 | $2,661,230 | $0 | 10.0% | |
| Pay: officers, directors, trustees, key employees | $3,939,371 | $1,374,797 | $2,564,574 | $0 | 6.1% | |
| Information technology | $1,798,924 | $1,573,136 | $225,788 | $0 | 2.8% | |
| Other employee benefits | $1,768,611 | $1,117,493 | $651,118 | $0 | 2.7% | |
| Payroll taxes | $1,636,694 | $757,605 | $879,089 | $0 | 2.5% | |
| Pension plan contributions | $779,315 | $494,925 | $284,390 | $0 | 1.2% | |
| Travel | $743,976 | $389,426 | $354,550 | $0 | 1.1% | |
| Fees: legal | $487,795 | $0 | $487,795 | $0 | 0.8% | |
| Conferences, conventions and meetings | $468,557 | $141,582 | $326,975 | $0 | 0.7% | |
| Occupancy | $424,420 | $178,113 | $246,307 | $0 | 0.7% | |
| Insurance | $400,087 | $72,703 | $327,384 | $0 | 0.6% | |
| Advertising and promotion | $270,240 | $6,960 | $263,280 | $0 | 0.4% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $155,923 | $21,406 | $134,517 | $0 | 0.2% |
| Other (as described) | RECRUITMENT | $143,330 | $70,484 | $72,846 | $0 | 0.2% |
| Fees: lobbying | $129,600 | $0 | $129,600 | $0 | 0.2% | |
| Interest | $85,749 | $15,418 | $70,331 | $0 | 0.1% | |
| Other (as described) | ALL OTHER EXPENSES | $72,008 | $65,437 | $6,571 | $0 | 0.1% |
| Fees: accounting | $53,738 | $5,641 | $48,097 | $0 | 0.1% | |
| Other (as described) | RELOCATION | $48,932 | $15,857 | $33,075 | $0 | 0.1% |
| Fees: investment management | $47,469 | $0 | $47,469 | $0 | 0.1% | |
| Total | $64,872,822 | 100% |
2017 · Form 990 · $57,255,533 spent · pay $26,788,086 · grants $0 · events $596,520
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $19,311,724 | $10,427,566 | $8,884,158 | - | 33.7% | |
| Fees: other services | $10,849,884 | $10,365,216 | $484,668 | $0 | 18.9% | |
| Office expenses | $8,381,009 | $6,931,648 | $1,449,361 | - | 14.6% | |
| Depreciation and depletion | $4,636,307 | $350,440 | $4,285,867 | - | 8.1% | |
| Pay: officers, directors, trustees, key employees | $3,774,089 | $1,526,927 | $2,247,162 | - | 6.6% | |
| Information technology | $2,845,861 | $896,637 | $1,949,224 | - | 5.0% | |
| Other employee benefits | $1,611,871 | $834,673 | $777,198 | - | 2.8% | |
| Payroll taxes | $1,401,085 | $725,522 | $675,563 | - | 2.4% | |
| Pension plan contributions | $689,317 | $356,948 | $332,369 | - | 1.2% | |
| Travel | $616,342 | $279,319 | $337,023 | - | 1.1% | |
| Conferences, conventions and meetings | $596,520 | $92,234 | $504,286 | - | 1.0% | |
| Fees: legal | $467,232 | - | $467,232 | - | 0.8% | |
| Insurance | $348,826 | $24,120 | $324,706 | - | 0.6% | |
| Fees: accounting | $328,847 | $7,516 | $321,331 | - | 0.6% | |
| Occupancy | $287,700 | $287,700 | - | - | 0.5% | |
| Advertising and promotion | $254,369 | $8,035 | $246,334 | - | 0.4% | |
| Other (as described) | BAD DEBT EXPENSE | $222,524 | - | $222,524 | - | 0.4% |
| Other (as described) | RELOCATION | $138,188 | $20,050 | $118,138 | - | 0.2% |
| Interest | $136,950 | $17,852 | $119,098 | - | 0.2% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $118,250 | $18,580 | $99,670 | - | 0.2% |
| All other expenses | $103,107 | - | $103,107 | - | 0.2% | |
| Fees: lobbying | $97,200 | $97,200 | - | - | 0.2% | |
| Other (as described) | RECRUITMENT | $38,331 | $2,132 | $36,199 | - | 0.1% |
| Total | $57,255,533 | 100% |
2016 · Form 990 · $44,361,873 spent · pay $20,438,519 · grants $0 · events $342,555
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $14,017,402 | $7,008,701 | $7,008,701 | - | 31.6% | |
| Fees: other services | $9,118,513 | $8,388,975 | $729,538 | $0 | 20.6% | |
| Office expenses | $6,159,336 | $3,079,668 | $3,079,668 | - | 13.9% | |
| Pay: officers, directors, trustees, key employees | $3,245,093 | $1,233,136 | $2,011,957 | - | 7.3% | |
| Depreciation and depletion | $2,499,578 | $1,874,684 | $624,894 | - | 5.6% | |
| Occupancy | $2,286,145 | $1,714,609 | $571,536 | - | 5.2% | |
| Other employee benefits | $1,518,021 | $728,650 | $789,371 | - | 3.4% | |
| Information technology | $1,494,352 | $747,176 | $747,176 | - | 3.4% | |
| Payroll taxes | $1,137,099 | $545,807 | $591,292 | - | 2.6% | |
| Pension plan contributions | $520,904 | $250,034 | $270,870 | - | 1.2% | |
| Fees: legal | $509,491 | - | $509,491 | - | 1.1% | |
| Travel | $362,408 | $144,963 | $217,445 | - | 0.8% | |
| Insurance | $355,933 | $35,593 | $320,340 | - | 0.8% | |
| Conferences, conventions and meetings | $342,555 | $137,022 | $205,533 | - | 0.8% | |
| All other expenses | $170,582 | $68,233 | $102,349 | - | 0.4% | |
| Advertising and promotion | $132,472 | - | $132,472 | - | 0.3% | |
| Fees: lobbying | $129,600 | $129,600 | - | - | 0.3% | |
| Fees: accounting | $102,819 | - | $102,819 | - | 0.2% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $83,946 | $33,478 | $50,468 | - | 0.2% |
| Other (as described) | SEMINARS & TRAINING | $53,446 | $21,378 | $32,068 | - | 0.1% |
| Other (as described) | RECRUITMENT | $49,023 | $19,609 | $29,414 | - | 0.1% |
| Interest | $40,860 | - | $40,860 | - | 0.1% | |
| Other (as described) | RELOCATION | $32,295 | $12,918 | $19,377 | - | 0.1% |
| Total | $44,361,873 | 100% |
2015 · Form 990 · $50,318,005 spent · pay $22,715,867 · grants $0 · events $315,461
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $14,535,740 | $7,415,522 | $7,120,218 | $0 | 28.9% | |
| Office expenses | $7,674,629 | $5,755,971 | $1,918,658 | $0 | 15.3% | |
| Fees: other services | $6,966,053 | $5,572,843 | $1,393,210 | - | 13.8% | |
| Occupancy | $5,932,661 | $4,449,496 | $1,483,165 | $0 | 11.8% | |
| Pay: officers, directors, trustees, key employees | $4,780,495 | $1,816,588 | $2,963,907 | $0 | 9.5% | |
| Depreciation and depletion | $2,963,029 | $2,222,272 | $740,757 | $0 | 5.9% | |
| Information technology | $1,739,383 | $869,692 | $869,691 | $0 | 3.5% | |
| Other employee benefits | $1,426,938 | $684,930 | $742,008 | $0 | 2.8% | |
| Payroll taxes | $1,267,487 | $608,394 | $659,093 | $0 | 2.5% | |
| Pension plan contributions | $545,411 | $261,797 | $283,614 | $0 | 1.1% | |
| Travel | $391,263 | $156,505 | $234,758 | $0 | 0.8% | |
| Fees: accounting | $371,861 | $0 | $371,861 | $0 | 0.7% | |
| Insurance | $342,938 | $34,294 | $308,644 | $0 | 0.7% | |
| Conferences, conventions and meetings | $315,461 | $126,184 | $189,277 | $0 | 0.6% | |
| Fees: legal | $280,062 | $0 | $280,062 | $0 | 0.6% | |
| All other expenses | $200,781 | $80,312 | $120,469 | - | 0.4% | |
| Pay: disqualified persons | $159,796 | - | $159,796 | $0 | 0.3% | |
| Fees: lobbying | $129,600 | $129,600 | $0 | $0 | 0.3% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $81,291 | $32,517 | $48,774 | $0 | 0.2% |
| Other (as described) | SEMINARS & TRAINING | $64,031 | $25,536 | $38,495 | $0 | 0.1% |
| Other (as described) | RECRUITMENT | $59,253 | $23,701 | $35,552 | $0 | 0.1% |
| Advertising and promotion | $51,523 | $0 | $51,523 | $0 | 0.1% | |
| Other (as described) | RELOCATION | $29,319 | $11,727 | $17,592 | $0 | 0.1% |
| Interest | $9,000 | $0 | $9,000 | $0 | 0.0% | |
| Total | $50,318,005 | 100% |
2014 · Form 990 · $56,395,883 spent · pay $25,596,001 · grants $0 · events $243,283
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $18,299,817 | $9,149,908 | $9,149,909 | $0 | 32.4% | |
| Office expenses | $8,012,196 | $6,009,147 | $2,003,049 | $0 | 14.2% | |
| Fees: other services | $7,079,666 | $5,663,733 | $1,415,933 | - | 12.6% | |
| Occupancy | $5,921,219 | $4,440,914 | $1,480,305 | $0 | 10.5% | |
| Depreciation and depletion | $5,216,729 | $3,912,547 | $1,304,182 | $0 | 9.3% | |
| Pay: officers, directors, trustees, key employees | $4,610,620 | $1,752,036 | $2,858,584 | $0 | 8.2% | |
| Information technology | $1,682,274 | $841,137 | $841,137 | $0 | 3.0% | |
| Payroll taxes | $1,371,684 | $658,408 | $713,276 | $0 | 2.4% | |
| Other employee benefits | $699,475 | $335,748 | $363,727 | $0 | 1.2% | |
| Pension plan contributions | $614,405 | $294,914 | $319,491 | $0 | 1.1% | |
| Fees: legal | $592,182 | $0 | $592,182 | $0 | 1.1% | |
| Travel | $430,820 | $172,328 | $258,492 | $0 | 0.8% | |
| Insurance | $424,859 | $42,486 | $382,373 | $0 | 0.8% | |
| All other expenses | $363,108 | $145,243 | $217,865 | - | 0.6% | |
| Fees: accounting | $358,992 | $0 | $358,992 | $0 | 0.6% | |
| Conferences, conventions and meetings | $243,283 | $97,313 | $145,970 | $0 | 0.4% | |
| Fees: lobbying | $118,800 | $118,800 | $0 | $0 | 0.2% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $102,057 | $40,823 | $61,234 | $0 | 0.2% |
| Other (as described) | SEMINARS & EDUCATION | $90,526 | $36,102 | $54,424 | $0 | 0.2% |
| Other (as described) | RELOCATION | $53,776 | $21,510 | $32,266 | $0 | 0.1% |
| Other (as described) | RECRUITMENT | $47,700 | $19,080 | $28,620 | $0 | 0.1% |
| Interest | $34,376 | - | $34,376 | $0 | 0.1% | |
| Advertising and promotion | $27,319 | $0 | $27,319 | $0 | 0.0% | |
| Total | $56,395,883 | 100% |
2013 · Form 990 · $57,794,435 spent · pay $26,747,949 · grants $0 · events $207,355
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $17,092,528 | $8,546,264 | $8,546,264 | $0 | 29.6% | |
| Office expenses | $7,633,379 | $5,725,034 | $1,908,345 | $0 | 13.2% | |
| Fees: other services | $7,395,096 | $5,894,477 | $1,500,619 | $0 | 12.8% | |
| Occupancy | $6,135,542 | $4,601,657 | $1,533,885 | $0 | 10.6% | |
| Pay: officers, directors, trustees, key employees | $5,913,383 | $2,247,086 | $3,666,297 | $0 | 10.2% | |
| Depreciation and depletion | $5,819,751 | $4,364,813 | $1,454,938 | $0 | 10.1% | |
| Payroll taxes | $1,594,295 | $765,262 | $829,033 | $0 | 2.8% | |
| Other employee benefits | $1,501,370 | $720,658 | $780,712 | $0 | 2.6% | |
| Information technology | $1,286,769 | $643,384 | $643,385 | $0 | 2.2% | |
| Fees: legal | $724,476 | - | $724,476 | $0 | 1.3% | |
| Pension plan contributions | $646,373 | $310,259 | $336,114 | $0 | 1.1% | |
| Travel | $480,037 | $192,015 | $288,022 | $0 | 0.8% | |
| Insurance | $406,909 | $40,691 | $366,218 | $0 | 0.7% | |
| Fees: accounting | $382,300 | - | $382,300 | $0 | 0.7% | |
| Conferences, conventions and meetings | $207,355 | $82,942 | $124,413 | $0 | 0.4% | |
| Interest | $167,130 | - | $167,130 | $0 | 0.3% | |
| Fees: lobbying | $108,000 | $108,000 | $0 | $0 | 0.2% | |
| Other (as described) | Dues & Subscriptions | $81,073 | $32,429 | $48,644 | $0 | 0.1% |
| All other expenses | $67,153 | $26,862 | $40,291 | - | 0.1% | |
| Other (as described) | SEMINARS & EDUCATION | $60,813 | $24,325 | $36,488 | - | 0.1% |
| Other (as described) | RELOCATION | $37,762 | $15,105 | $22,657 | - | 0.1% |
| Advertising and promotion | $33,798 | - | $33,798 | $0 | 0.1% | |
| Other (as described) | Recruitment | $19,143 | $7,657 | $11,486 | $0 | 0.0% |
| Total | $57,794,435 | 100% |
2011 · Form 990 · $57,632,572 spent · pay $26,595,987 · grants $0 · events $331,727
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $18,586,777 | $9,341,094 | $9,245,683 | - | 32.3% | |
| Office expenses | $8,639,072 | $6,479,304 | $2,159,768 | - | 15.0% | |
| Fees: other services | $6,807,854 | $5,437,827 | $1,370,027 | - | 11.8% | |
| Occupancy | $6,307,888 | $4,730,916 | $1,576,972 | - | 10.9% | |
| Depreciation and depletion | $5,191,851 | $3,893,888 | $1,297,963 | - | 9.0% | |
| Pay: officers, directors, trustees, key employees | $4,087,276 | $1,542,451 | $2,544,825 | - | 7.1% | |
| Other employee benefits | $1,733,477 | $832,069 | $901,408 | - | 3.0% | |
| Payroll taxes | $1,515,576 | $727,476 | $788,100 | - | 2.6% | |
| Information technology | $1,315,054 | $657,527 | $657,527 | - | 2.3% | |
| Pension plan contributions | $672,881 | $322,983 | $349,898 | - | 1.2% | |
| Travel | $636,140 | $254,456 | $381,684 | - | 1.1% | |
| Fees: legal | $587,042 | $0 | $587,042 | - | 1.0% | |
| Insurance | $375,001 | $37,500 | $337,501 | - | 0.7% | |
| Conferences, conventions and meetings | $331,727 | $132,691 | $199,036 | - | 0.6% | |
| Interest | $305,378 | - | $305,378 | - | 0.5% | |
| Other (as described) | ALL OTHER EXPENSES | $190,943 | $76,377 | $114,566 | - | 0.3% |
| Fees: accounting | $132,090 | $0 | $132,090 | - | 0.2% | |
| Other (as described) | SEMINARS AND EDUCATION | $109,437 | $43,775 | $65,662 | - | 0.2% |
| Other (as described) | DUES AND SUBSCRIPTIONS | $43,873 | $17,549 | $26,324 | - | 0.1% |
| Advertising and promotion | $33,450 | $0 | $33,450 | - | 0.1% | |
| Other (as described) | RECRUITMENT | $29,785 | $11,914 | $17,871 | - | 0.1% |
| Total | $57,632,572 | 100% |
2010 · Form 990 · $73,173,514 spent · pay $28,036,987 · grants $0 · events $335,860
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $20,133,665 | $13,543,763 | $6,589,902 | - | 27.5% | |
| Fees: other services | $12,408,389 | $9,306,292 | $3,102,097 | - | 17.0% | |
| Office expenses | $10,927,299 | $8,195,474 | $2,731,825 | - | 14.9% | |
| Depreciation and depletion | $6,070,352 | $4,552,764 | $1,517,588 | - | 8.3% | |
| Other (as described) | RELEASED FROM RESTRICTIONS | $5,785,295 | $5,785,295 | $0 | - | 7.9% |
| Occupancy | $5,602,717 | $4,202,038 | $1,400,679 | - | 7.7% | |
| Pay: officers, directors, trustees, key employees | $3,906,893 | $880,572 | $3,026,321 | - | 5.3% | |
| Other employee benefits | $1,649,452 | $989,671 | $659,781 | - | 2.3% | |
| Payroll taxes | $1,640,502 | $984,301 | $656,201 | - | 2.2% | |
| Travel | $1,215,944 | $486,378 | $729,566 | - | 1.7% | |
| Information technology | $953,081 | $714,811 | $238,270 | - | 1.3% | |
| Pension plan contributions | $706,475 | $423,885 | $282,590 | - | 1.0% | |
| Fees: accounting | $583,045 | - | $583,045 | - | 0.8% | |
| Fees: legal | $539,388 | - | $539,388 | - | 0.7% | |
| Interest | $340,469 | - | $340,469 | - | 0.5% | |
| Conferences, conventions and meetings | $335,860 | $134,344 | $201,516 | - | 0.5% | |
| Insurance | $235,484 | $11,774 | $223,710 | - | 0.3% | |
| Other (as described) | ALL OTHER EXPENSES | $74,174 | $62,765 | $11,409 | - | 0.1% |
| Advertising and promotion | $65,030 | - | $65,030 | - | 0.1% | |
| Total | $73,173,514 | 100% |
2009 · Form 990 · $67,133,632 spent · pay $26,404,168 · grants $0 · events $284,692
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $18,752,245 | $12,640,338 | $6,111,907 | $0 | 27.9% | |
| Office expenses | $14,433,866 | $11,964,444 | $2,469,422 | $0 | 21.5% | |
| Fees: other services | $10,394,015 | $9,600,338 | $793,677 | $0 | 15.5% | |
| Depreciation and depletion | $6,627,832 | $5,037,152 | $1,590,680 | $0 | 9.9% | |
| Occupancy | $6,207,500 | $4,666,746 | $1,540,754 | $0 | 9.2% | |
| Pay: officers, directors, trustees, key employees | $4,132,204 | $0 | $4,132,204 | $0 | 6.2% | |
| Payroll taxes | $1,585,389 | $871,964 | $713,425 | $0 | 2.4% | |
| Other employee benefits | $1,208,398 | $714,619 | $493,779 | $0 | 1.8% | |
| Travel | $948,372 | $312,963 | $635,409 | $0 | 1.4% | |
| Pension plan contributions | $725,932 | $399,263 | $326,669 | $0 | 1.1% | |
| Fees: legal | $644,725 | $0 | $644,725 | $0 | 1.0% | |
| Interest | $432,397 | $0 | $432,397 | $0 | 0.6% | |
| Fees: accounting | $363,501 | $0 | $363,501 | $0 | 0.5% | |
| Insurance | $289,348 | $9,621 | $279,727 | $0 | 0.4% | |
| Conferences, conventions and meetings | $284,692 | $133,805 | $150,887 | $0 | 0.4% | |
| Other (as described) | RELOCATION | $118,603 | $20,376 | $98,227 | $0 | 0.2% |
| Other (as described) | SEMINARS AND EDUCATION | $118,569 | $17,785 | $100,784 | $0 | 0.2% |
| Other (as described) | DUES AND SUBSCRIPTIONS | $93,496 | $22,983 | $70,513 | $0 | 0.1% |
| Other (as described) | RECRUITMENT | $57,126 | $5,996 | $51,130 | $0 | 0.1% |
| Advertising and promotion | $13,343 | $0 | $13,343 | $0 | 0.0% | |
| Other (as described) | ALL OTHER EXPENSES | -$297,921 | $0 | -$297,921 | $0 | -0.4% |
| Total | $67,133,632 | 100% |
Federal lobbying
Lobbying Disclosure Act reports naming a client or registrant with this organization's name and state. Spent: what lobbying for it cost (firm income plus its own reported expenses). Earned: income it reported as a lobbying firm.
| Year | Spent | Earned | Reports |
|---|---|---|---|
| 2026 | $30,000 | 3 | |
| 2025 | $40,000 | 4 | |
| 2024 | $40,000 | 4 | |
| 2023 | $40,000 | 4 | |
| 2022 | $40,000 | 4 | |
| 2021 | $80,000 | 4 | |
| 2020 | $200,000 | 4 | |
| 2019 | $200,000 | 4 | |
| 2018 | $250,000 | 5 | |
| 2017 | $250,000 | 5 | |
| 2016 | $200,000 | 4 | |
| 2015 | $200,000 | 4 | |
| 2014 | $200,000 | 4 | |
| 2013 | $200,000 | 4 | |
| 2012 | $200,000 | 4 | |
| 2011 | $200,000 | 4 | |
| 2010 | $200,000 | 4 | |
| 2009 | $110,000 | 4 | |
| 2008 | $80,000 | 4 | |
| 2007 | $80,000 | 2 | |
| 2006 | $80,000 | 2 | |
| 2005 | $20,000 | 3 |
Issues: Budget/Appropriations, Defense, Medical/Disease Research/Clinical Labs, Health Issues, Science/Technology
Firms hired: FIRST STRATEGIC
Federal grants and contracts
Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.
| Fiscal year | Grants and other assistance | Contracts | Awards |
|---|---|---|---|
| 2026 | $13,057,054 | $1,527,356 | 17 |
| 2025 | $5,055,328 | $1,211,936 | 16 |
| 2024 | $5,489,769 | $1,570,991 | 15 |
| 2023 | $9,918,112 | $5,340,000 | 23 |
| 2022 | $5,262,341 | $127,803 | 22 |
| 2021 | $4,370,754 | $1,089,859 | 18 |
| 2020 | $5,685,538 | $410,050 | 19 |
| 2019 | $6,404,094 | $380,204 | 16 |
| 2018 | $4,313,366 | $1,437,742 | 9 |
| 2017 | $2,482,131 | $1,005,909 | 9 |
| 2016 | $3,241,573 | $1,705,463 | 9 |
| 2015 | $4,607,917 | $347,043 | 11 |
| 2014 | $4,901,087 | $339,996 | 11 |
| 2013 | $4,650,322 | $0 | 12 |
| 2012 | $4,427,434 | $293,559 | 11 |
| 2011 | $6,770,305 | $542,441 | 13 |
| 2010 | $11,901,133 | $840,797 | 21 |
| 2009 | $19,275,715 | $0 | 20 |
| 2008 | $8,733,730 | $31,500 | 13 |
| 2007 | $6,574,493 | $429,309 | 17 |
Largest awards · 200 shown
| Year | Agency | Kind | Program | Description | Obligated |
|---|---|---|---|---|---|
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | CONSORTIUM TO STUDY THE GENETICS OF LONGEVITY | $8,901,377 |
| 2026 | National Institutes of Health | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714 | MYCOBACTERIUM TUBERCULOSIS PROTEOME-WIDE EPITOPE DISCOVERY AND HOST TRANSCRIPTOME-WIDE T CELL PHENOTYPING IN HIGH DISEASE BURDEN POPULATIONS | $1,542,506 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | HIGH-RESOLUTION, VIROME-WIDE INFECTION ANALYSIS IN TYPE 1 DIABETES BIRTH COHORTS - PROJECT ABSTRACT/SUMMARY TYPE 1 DIABETES (T1D) AFFECTS >20 MILLION PEOPLE GLO | $1,029,312 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | COMBINING GENOME, FUNCTION, AND PHENOTYPE TO DEFINE THE CELL TYPE SPECIFIC GENE REGULATORY ARCHITECTURE OF IDIOPATHIC PULMONARY FIBROSIS | $807,795 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | THE ROLE OF CLU IN MOLECULAR PATHOGENESIS OF ALZHEIMERS DISEASE - PROJECT SUMMARY/ABSTRACT ALZHEIMER’S DISEASE (AD) AFFECTS OVER SIX MILLION AMERICANS AND IS MA | $798,749 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EXTRACELLULAR VESICLE CARGO AND RISK OF NAFLD AND NASH IN LATINO YOUTH - PROJECT SUMMARY/ABSTRACT THE PREVALENCE OF PEDIATRIC NONALCOHOLIC FATTY LIVER DISEASE ( | $756,297 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | MOLECULAR CARTOGRAPHY OF INITIATING AND INFILTRATING GLIOMA CELLS USING MULTISECTOR SAMPLING AND SPATIAL TRANSCRIPTOMICS - SUMMARY DIFFUSE DISSEMINATION OF TUMO | $305,960 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | DISSECTING SPATIOTEMPORAL HETEROGENEITY OF GLIOBLASTOMA EVOLUTION UNDER THERAPY - PROJECT SUMMARY: GLIOBLASTOMA (GBM) IS AN UNCURABLE FORM OF PRIMARY BRAIN TUMO | $248,999 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING CELLULAR SENESCENSE IN PANCREATIC CANCER - PROJECT SUMMARY CELLULAR SENESCENCE IS A STRESS RESPONSE THAT IMPOSES A GROWTH ARREST ON CANCER AND NONMAL | $224,400 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | IDENTIFYING KEY MOLECULAR DIFFERENCES BETWEEN LEWY BODY AND ALZHEIMER'S DISEASE VIA MULTI-OMICS ANALYSIS - PROJECT SUMMARY: DEMENTIA AFFECTS NEARLY 7 MILLION AM | $123,066 |
| 2026 | National Institutes of Health | Contract | TESTING LABORATORIES AND SERVICES 541380 | GENOME SEQUENCING OF DNA SAMPLES OF DRUG-RESISTANT FORMS TB BACTERIA | -$15,150 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | INTEGRATIVE OMICS TO ENHANCE THERAPEUTICS DEVELOPMENT FOR HEALTHY AGING - ABSTRACT/SUMMARY A NUMBER OF DRUGS AND INTERVENTIONS HAVE BEEN IDENTIFIED THAT CURB MO | -$55,782 |
| 2026 | Animal and Plant Health Inspection Service | Grant or other assistance | PLANT AND ANIMAL DISEASE, PEST CONTROL, AND ANIMAL CARE 10.025 | THE PURPOSE OF THIS AWARD IS TO ADDRESS GAPS IN SURVEILLANCE AND INVESTIGATION ACTIVITIES FOR SARS-COV-2 IN ANIMALS, INCLUDING FARMED ANIMALS, CAPTIVE WILDLIFE, | -$83,117 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | HIGH-RESOLUTION, VIROME-WIDE INFECTION ANALYSIS IN TYPE 1 DIABETES BIRTH COHORTS - PROJECT ABSTRACT/SUMMARY TYPE 1 DIABETES (T1D) AFFECTS >20 MILLION PEOPLE GLO | $1,178,146 |
| 2025 | National Institutes of Health | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714 | MYCOBACTERIUM TUBERCULOSIS PROTEOME-WIDE EPITOPE DISCOVERY AND HOST TRANSCRIPTOME-WIDE T CELL PHENOTYPING IN HIGH DISEASE BURDEN POPULATIONS | $1,040,738 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | COMBINING GENOME, FUNCTION, AND PHENOTYPE TO DEFINE THE CELL TYPE SPECIFIC GENE REGULATORY ARCHITECTURE OF IDIOPATHIC PULMONARY FIBROSIS | $824,280 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EXTRACELLULAR VESICLE CARGO AND RISK OF NAFLD AND NASH IN LATINO YOUTH - PROJECT SUMMARY/ABSTRACT THE PREVALENCE OF PEDIATRIC NONALCOHOLIC FATTY LIVER DISEASE ( | $766,552 |
| 2025 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | INTEGRATED ANALYSIS OF MULTI-OMIC QTLS AT SINGLE CELL RESOLUTION - PROJECT SUMMARY NOVEL STATISTICAL AND COMPUTATIONAL TOOLS HAVE ENABLED THE BROAD ADOPTION OF | $680,777 |
| 2025 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | MITOCHONDRIAL METHIONYL-TRNA FORMYLTRANSFERASE (MTFMT) MOUSE MODEL TO ELUCIDATE MITOCHONDRIAL TRANSLATION INITIATION DEFECT AND DISEASE MECHANISMS IN LEIGH SYND | $543,351 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | SINGLE: SIGNATURE ENABLING GLIOMA ENROLLMENT | $384,000 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING CELLULAR SENESCENSE IN PANCREATIC CANCER - PROJECT SUMMARY CELLULAR SENESCENCE IS A STRESS RESPONSE THAT IMPOSES A GROWTH ARREST ON CANCER AND NONMAL | $269,280 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | PROTEOME-WIDE DISCOVERY OF DIAGNOSTIC TARGETS FOR COCCIDIOIDOMYCOSIS - PROJECT SUMMARY ANTIBODY MEDIATED IMMUNITY HAS LONG BEEN CONSIDERED IRRELEVANT TO THE DIS | $216,965 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | SINGLE: SIGNATURE ENABLING GLIOMA ENROLLMENT | $192,000 |
| 2025 | National Institutes of Health | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | PILOT STUDY OF HOW SEX DIFFERENCES IN EARLY LIFE UNDERLIE DEVELOPMENTAL ORIGINS OF DISEASE | $171,198 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | GENETIC AND EPIGENETIC STRATEGIES FOR THE ACQUISITION OF TELOMERE MAINTENANCE IN HUMAN CANCER CELLS - PROJECT SUMMARY/ABSTRACT TELOMERASE REACTIVATION IS A FUND | -$22 |
| 2024 | National Institutes of Health | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714 | MYCOBACTERIUM TUBERCULOSIS PROTEOME-WIDE EPITOPE DISCOVERY AND HOST TRANSCRIPTOME-WIDE T CELL PHENOTYPING IN HIGH DISEASE BURDEN POPULATIONS | $1,504,937 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | HIGH-RESOLUTION, VIROME-WIDE INFECTION ANALYSIS IN TYPE 1 DIABETES BIRTH COHORTS - PROJECT ABSTRACT/SUMMARY TYPE 1 DIABETES (T1D) AFFECTS >20 MILLION PEOPLE GLO | $1,281,272 |
| 2024 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | COMBINING GENOME, FUNCTION, AND PHENOTYPE TO DEFINE THE CELL TYPE SPECIFIC GENE REGULATORY ARCHITECTURE OF IDIOPATHIC PULMONARY FIBROSIS | $847,280 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EXTRACELLULAR VESICLE CARGO AND RISK OF NAFLD AND NASH IN LATINO YOUTH - PROJECT SUMMARY/ABSTRACT THE PREVALENCE OF PEDIATRIC NONALCOHOLIC FATTY LIVER DISEASE ( | $751,351 |
| 2024 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | INTEGRATED ANALYSIS OF MULTI-OMIC QTLS AT SINGLE CELL RESOLUTION - PROJECT SUMMARY NOVEL STATISTICAL AND COMPUTATIONAL TOOLS HAVE ENABLED THE BROAD ADOPTION OF | $723,861 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PROFILING EXTRACELLULAR VESICLE CARGO IN OBESITY AND TYPE 2 DIABETES | $711,554 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | A SCALABLE PLATFORM FOR HIGHLY-MULTIPLEXED ANALYSIS OF ANTIBODY REACTIVITY FROM <1UL OF BLOOD | $505,400 |
| 2024 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | INTEGRATIVE OMICS TO ENHANCE THERAPEUTICS DEVELOPMENT FOR HEALTHY AGING - ABSTRACT/SUMMARY A NUMBER OF DRUGS AND INTERVENTIONS HAVE BEEN IDENTIFIED THAT CURB MO | $390,000 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | PROTEOME-WIDE DISCOVERY OF DIAGNOSTIC TARGETS FOR COCCIDIOIDOMYCOSIS - PROJECT SUMMARY ANTIBODY MEDIATED IMMUNITY HAS LONG BEEN CONSIDERED IRRELEVANT TO THE DIS | $307,028 |
| 2024 | National Institutes of Health | Contract | MEDICAL LABORATORIES 621511 | LONG READ RNA SEQUENCING SERVICES | $66,054 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | CHARACTERIZING THE EFFECTS OF CIS-REGULATORY VARIATION ON PATIENT OUTCOMES AND TREATMENT RESPONSE IN MULTIPLE MYELOMA - ABSTRACT MULTIPLE MYELOMA (MM) IS A MALI | -$27,976 |
| 2023 | Animal and Plant Health Inspection Service | Contract | TESTING LABORATORIES AND SERVICES 541380 | SARS-COV-2 SAMPLE COLLECTION AND BIOSECURITY ASSESSMENT IN WILDLIFE REHABILITATION FACILITIES | $5,340,000 |
| 2023 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | A LARGE-SCALE EXTRACELLULAR VESICLE RNA-SEQ RESOURCE FOR PARKINSONS DISEASE - PROJECT SUMMARY/ABSTRACT PARKINSON'S DISEASE (PD) IS A DEVASTATING AND PROGRESSIVE | $2,250,030 |
| 2023 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | GENOMIC DISSECTION OF STRUCTURAL MUTATIONS FOLLOWING TELOMERE DYSFUNCTION IN GLIOBLASTOMA CELLS AND PATIENTS | $1,535,920 |
| 2023 | Animal and Plant Health Inspection Service | Grant or other assistance | PLANT AND ANIMAL DISEASE, PEST CONTROL, AND ANIMAL CARE 10.025 | THE PURPOSE OF THIS AWARD IS TO ADDRESS GAPS IN SURVEILLANCE AND INVESTIGATION ACTIVITIES FOR SARS-COV-2 IN ANIMALS, INCLUDING FARMED ANIMALS, CAPTIVE WILDLIFE, | $1,300,003 |
| 2023 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | INTEGRATIVE OMICS TO ENHANCE THERAPEUTICS DEVELOPMENT FOR HEALTHY AGING - ABSTRACT/SUMMARY A NUMBER OF DRUGS AND INTERVENTIONS HAVE BEEN IDENTIFIED THAT CURB MO | $878,314 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EXTRACELLULAR VESICLE CARGO AND RISK OF NAFLD AND NASH IN LATINO YOUTH - PROJECT SUMMARY/ABSTRACT THE PREVALENCE OF PEDIATRIC NONALCOHOLIC FATTY LIVER DISEASE ( | $783,329 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PROFILING EXTRACELLULAR VESICLE CARGO IN OBESITY AND TYPE 2 DIABETES | $753,384 |
| 2023 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | INTEGRATED ANALYSIS OF MULTI-OMIC QTLS AT SINGLE CELL RESOLUTION - PROJECT SUMMARY NOVEL STATISTICAL AND COMPUTATIONAL TOOLS HAVE ENABLED THE BROAD ADOPTION OF | $745,421 |
| 2023 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | COMBINING GENOME, FUNCTION, AND PHENOTYPE TO DEFINE THE CELL TYPE SPECIFIC GENE REGULATORY ARCHITECTURE OF IDIOPATHIC PULMONARY FIBROSIS | $701,261 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | A SCALABLE PLATFORM FOR HIGHLY-MULTIPLEXED ANALYSIS OF ANTIBODY REACTIVITY FROM <1UL OF BLOOD | $505,400 |
| 2023 | Agricultural Research Service | Grant or other assistance | AGRICULTURAL RESEARCH BASIC AND APPLIED RESEARCH 10.001 | SOUTHWESTERN USA ARBOVIRUS LANDSCAPE | $250,000 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | GENETIC AND EPIGENETIC STRATEGIES FOR THE ACQUISITION OF TELOMERE MAINTENANCE IN HUMAN CANCER CELLS - PROJECT SUMMARY/ABSTRACT TELOMERASE REACTIVATION IS A FUND | $244,019 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | CHARACTERIZING THE EFFECTS OF CIS-REGULATORY VARIATION ON PATIENT OUTCOMES AND TREATMENT RESPONSE IN MULTIPLE MYELOMA - ABSTRACT MULTIPLE MYELOMA (MM) IS A MALI | $80,804 |
| 2023 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | HOST DNA METHYLATION AS A MECHANISM OF MICROBIOME INFLUENCE ON INTERNALIZING BEHAVIOR | -$36,081 |
| 2023 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | EXRNA SIGNATURES PREDICT OUTCOMES AFTER BRAIN INJURY | -$73,690 |
| 2022 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | INTEGRATIVE OMICS TO ENHANCE THERAPEUTICS DEVELOPMENT FOR HEALTHY AGING - ABSTRACT/SUMMARY A NUMBER OF DRUGS AND INTERVENTIONS HAVE BEEN IDENTIFIED THAT CURB MO | $1,173,619 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EXTRACELLULAR VESICLE CARGO AND RISK OF NAFLD AND NASH IN LATINO YOUTH - PROJECT SUMMARY/ABSTRACT THE PREVALENCE OF PEDIATRIC NONALCOHOLIC FATTY LIVER DISEASE ( | $852,047 |
| 2022 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | INTEGRATED ANALYSIS OF MULTI-OMIC QTLS AT SINGLE CELL RESOLUTION - PROJECT SUMMARY NOVEL STATISTICAL AND COMPUTATIONAL TOOLS HAVE ENABLED THE BROAD ADOPTION OF | $788,651 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PROFILING EXTRACELLULAR VESICLE CARGO IN OBESITY AND TYPE 2 DIABETES | $762,986 |
| 2022 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | COMBINING GENOME, FUNCTION, AND PHENOTYPE TO DEFINE THE CELL TYPE SPECIFIC GENE REGULATORY ARCHITECTURE OF IDIOPATHIC PULMONARY FIBROSIS | $701,261 |
| 2022 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | A SCALABLE PLATFORM FOR HIGHLY-MULTIPLEXED ANALYSIS OF ANTIBODY REACTIVITY FROM <1UL OF BLOOD | $566,656 |
| 2022 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | GENETIC AND EPIGENETIC STRATEGIES FOR THE ACQUISITION OF TELOMERE MAINTENANCE IN HUMAN CANCER CELLS - PROJECT SUMMARY/ABSTRACT TELOMERASE REACTIVATION IS A FUND | $244,019 |
| 2022 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | IDENTIFICATION OF NOVEL BLOOD-BASED BIOMARKERS OF ALZHEIMER'S DISEASE BY PSEUDOTIME ANALYSIS - PROJECT SUMMARY ALZHEIMER'S DISEASE (AD) IS THE MOST PREVALENT NE | $192,000 |
| 2022 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | GENOMIC DETERMINANTS OF SLEEP TRAITS AS RISK AND PROTECTIVE FACTORS FOR ALZHEIMER'S DISEASE - PROJECT SUMMARY ALZHEIMER'S DISEASE (AD) IS THE MOST PREVALENT NEU | $192,000 |
| 2022 | Centers for Disease Control and Prevention | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714 | RUN DATA SAMPLES | $145,000 |
| 2022 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | CHARACTERIZING THE EFFECTS OF CIS-REGULATORY VARIATION ON PATIENT OUTCOMES AND TREATMENT RESPONSE IN MULTIPLE MYELOMA - ABSTRACT MULTIPLE MYELOMA (MM) IS A MALI | $78,548 |
| 2022 | Department of Veterans Affairs | Contract | TESTING LABORATORIES 541380 | TGEN RESEARCH | $59,828 |
| 2022 | Indian Health Service | Contract | MEDICAL LABORATORIES 621511 | COVID19 (SARS-COV2) TESTING TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (LAB). | -$25,675 |
| 2022 | Indian Health Service | Contract | MEDICAL LABORATORIES 621511 | FY20 COVID TESTE WRSU;1000 SARS-COV2 NP PCR TESTS - $51.35 EA | -$51,350 |
| 2022 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | CROSS-SPECIES ANALYSIS TO IDENTIFY CONSERVE LONGEVITY-RELATED PATHWAYS AND PUTATIVE DRUG TARGETS | -$289,446 |
| 2021 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | INTEGRATIVE OMICS TO ENHANCE THERAPEUTICS DEVELOPMENT FOR HEALTHY AGING - ABSTRACT/SUMMARY A NUMBER OF DRUGS AND INTERVENTIONS HAVE BEEN IDENTIFIED THAT CURB MO | $1,106,634 |
| 2021 | Centers for Disease Control and Prevention | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | FY 21 BAA TOPIC 8 - TGRI | $1,074,709 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | A SCALABLE PLATFORM FOR HIGHLY-MULTIPLEXED ANALYSIS OF ANTIBODY REACTIVITY FROM <1UL OF BLOOD | $843,334 |
| 2021 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | COMBINING GENOME, FUNCTION, AND PHENOTYPE TO DEFINE THE CELL TYPE SPECIFIC GENE REGULATORY ARCHITECTURE OF IDIOPATHIC PULMONARY FIBROSIS | $701,261 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | PRE-ANALYTICAL FACTORS AFFECTING CTDNA ANALYSIS IN EARLY AND LOCALLY ADVANCED BREAST CANCER | $371,103 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | INDIVIDUALIZED MONITORING OF TREATMENT RESPONSE AND RESISTANCE IN PATIENTS WITH METASTATIC MELANOMA | $351,300 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | UNDERSTANDING THE NATURAL COCCIDIOIDES BIOAEROSOL IN TIME AND SPACE AND ITS RELATIONSHIP TO DISEASE | $287,269 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | A NOVEL APPROACH FOR DEEP PHENOTYPING THE CD4 T CELL RESPONSE TO MYCOBACTERIUM TUBERCULOSIS | $280,275 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | GENETIC AND EPIGENETIC STRATEGIES FOR THE ACQUISITION OF TELOMERE MAINTENANCE IN HUMAN CANCER CELLS - PROJECT SUMMARY/ABSTRACT TELOMERASE REACTIVATION IS A FUND | $249,021 |
| 2021 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | HOST DNA METHYLATION AS A MECHANISM OF MICROBIOME INFLUENCE ON INTERNALIZING BEHAVIOR | $103,415 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | CHARACTERIZING THE EFFECTS OF CIS-REGULATORY VARIATION ON PATIENT OUTCOMES AND TREATMENT RESPONSE IN MULTIPLE MYELOMA - ABSTRACT MULTIPLE MYELOMA (MM) IS A MALI | $77,142 |
| 2021 | National Institutes of Health | Contract | TESTING LABORATORIES 541380 | GENOME SEQUENCING OF DNA SAMPLES OF DRUG-RESISTANT FORMS TB BACTERIA | $15,150 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | A SCALABLE PLATFORM FOR HIGHLY-MULTIPLEXED ANALYSIS OF ANTIBODY REACTIVITY FROM <1UL OF BLOOD | $854,188 |
| 2020 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | CROSS-SPECIES ANALYSIS TO IDENTIFY CONSERVE LONGEVITY-RELATED PATHWAYS AND PUTATIVE DRUG TARGETS | $776,299 |
| 2020 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PROFILING EXTRACELLULAR VESICLE CARGO IN OBESITY AND TYPE 2 DIABETES | $722,401 |
| 2020 | National Institutes of Health | Grant or other assistance | LUNG DISEASES RESEARCH 93.838 | COMBINING GENOME, FUNCTION, AND PHENOTYPE TO DEFINE THE CELL TYPE SPECIFIC GENE REGULATORY ARCHITECTURE OF IDIOPATHIC PULMONARY FIBROSIS | $710,761 |
| 2020 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EPIGENETIC MARKERS OF SEVERITY IN NONALCOHOLIC FATTY LIVER DISEASE | $553,850 |
| 2020 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | PRE-ANALYTICAL FACTORS AFFECTING CTDNA ANALYSIS IN EARLY AND LOCALLY ADVANCED BREAST CANCER | $419,136 |
| 2020 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | INDIVIDUALIZED MONITORING OF TREATMENT RESPONSE AND RESISTANCE IN PATIENTS WITH METASTATIC MELANOMA | $415,333 |
| 2020 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | TREATMENT MONITORING IN EARLY AND LOCALLY ADVANCED BREAST CANCER USING CIRCULATING TUMOR DNA ANALYSIS | $309,491 |
| 2020 | Office of Procurement Operations | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712 | IGF::CL,CT::IGF RESEARCH AND DEVELOPMENT SERVICES FOR THE DEPARTMENT OF HOMELAND SECURITY, SCIENCE AND TECHNOLOGY DIRECTORATE, CHEMICAL AND BIOLOGICAL DEFENSE | $256,000 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | A NOVEL APPROACH FOR DEEP PHENOTYPING THE CD4 T CELL RESPONSE TO MYCOBACTERIUM TUBERCULOSIS | $255,206 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | UNDERSTANDING THE NATURAL COCCIDIOIDES BIOAEROSOL IN TIME AND SPACE AND ITS RELATIONSHIP TO DISEASE | $239,767 |
| 2020 | National Science Foundation | Grant or other assistance | BIOLOGICAL SCIENCES 47.074 | RAPID: COMPREHENSIVE INTERACTION AND ANNOTATION (CIA) ANALYSIS OF THE SARS-COV-2 GENOME AND RELATED GENOMES | $199,999 |
| 2020 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | CHARACTERIZATION OF THE ROLE OF SUPER-ENHANCERS IN OVARIAN CANCER TREATMENT RESPONSE | $138,428 |
| 2020 | Indian Health Service | Contract | MEDICAL LABORATORIES 621511 | COVID19 (SARS-COV2) TESTING TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (LAB). | $102,700 |
| 2020 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | HOST DNA METHYLATION AS A MECHANISM OF MICROBIOME INFLUENCE ON INTERNALIZING BEHAVIOR | $90,680 |
| 2020 | Indian Health Service | Contract | MEDICAL LABORATORIES 621511 | FY20 COVID TESTE WRSU;1000 SARS-COV2 NP PCR TESTS - $51.35 EA | $51,350 |
| 2020 | National Institutes of Health | Grant or other assistance | NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 93.350 | EXRNA SIGNATURES PREDICT OUTCOMES AFTER BRAIN INJURY | -$1 |
| 2019 | Department of the Army | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | INTEGRATED MOLECULAR PATHOGENESIS OF PULMONARY FIBROSIS | $1,462,194 |
| 2019 | Department of the Army | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | GENOTYPIC AND PHENOTYPIC EXAMINATION OF DISEASE PATHOGENESIS IN C9ORF72 FTD | $1,116,000 |
| 2019 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EPIGENETIC MARKERS OF SEVERITY IN NONALCOHOLIC FATTY LIVER DISEASE | $833,654 |
| 2019 | National Institutes of Health | Grant or other assistance | LUNG DISEASES RESEARCH 93.838 | COMBINING GENOME, FUNCTION, AND PHENOTYPE TO DEFINE THE CELL TYPE SPECIFIC GENE REGULATORY ARCHITECTURE OF IDIOPATHIC PULMONARY FIBROSIS | $753,281 |
| 2019 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PROFILING EXTRACELLULAR VESICLE CARGO IN OBESITY AND TYPE 2 DIABETES | $712,558 |
| 2019 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | CROSS-SPECIES ANALYSIS TO IDENTIFY CONSERVE LONGEVITY-RELATED PATHWAYS AND PUTATIVE DRUG TARGETS | $599,100 |
| 2019 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | PRE-ANALYTICAL FACTORS AFFECTING CTDNA ANALYSIS IN EARLY AND LOCALLY ADVANCED BREAST CANCER | $440,008 |
| 2019 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | INDIVIDUALIZED MONITORING OF TREATMENT RESPONSE AND RESISTANCE IN PATIENTS WITH METASTATIC MELANOMA | $402,872 |
| 2019 | Centers for Disease Control and Prevention | Contract | OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690 | IGF::OT::IGF BIOINFORMATICS SUPPORT SERVICES | $380,204 |
| 2019 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | CHARACTERIZATION OF THE ROLE OF SUPER-ENHANCERS IN OVARIAN CANCER TREATMENT RESPONSE | $84,428 |
| 2019 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | SYSTEMATIC DEVELOPMENT OF NOVEL, DRUGGABLE CANCER TARGETS | -$1 |
| 2018 | Department of the Army | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | RON KINASE AS A MULTIFACETED THERAPEUTIC TARGET FOR METASTATIC BREAST CANCER | $3,386,423 |
| 2018 | Office of Procurement Operations | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712 | IGF::CL,CT::IGF RESEARCH AND DEVELOPMENT SERVICES FOR THE DEPARTMENT OF HOMELAND SECURITY, SCIENCE AND TECHNOLOGY DIRECTORATE, CHEMICAL AND BIOLOGICAL DEFENSE | $1,065,688 |
| 2018 | National Institute of Food and Agriculture | Grant or other assistance | AGRICULTURE AND FOOD RESEARCH INITIATIVE (AFRI) 10.310 | THE OVERARCHING LONG-TERM GOAL OF THIS PROJECT IS TO IMPROVE FOOD-BORNE DISEASE (FBD) SURVEILLANCE AND DETECTION TECHNOLOGY THAT WILL ALLOW FOR THE EVENTUAL RED | $469,220 |
| 2018 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | INDIVIDUALIZED MONITORING OF TREATMENT RESPONSE AND RESISTANCE IN PATIENTS WITH METASTATIC MELANOMA | $457,723 |
| 2018 | Centers for Disease Control and Prevention | Contract | OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690 | IGF::OT::IGF BIOINFORMATICS SUPPORT SERVICES | $372,054 |
| 2017 | National Institutes of Health | Grant or other assistance | NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 93.350 | EXRNA SIGNATURES PREDICT OUTCOMES AFTER BRAIN INJURY | $1,027,246 |
| 2017 | Department of the Army | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | PHENOTYPIC VARIABILITY IN TUBEROUS SCLEROSIS COMPLEX (TSC) | $767,189 |
| 2017 | Office of Procurement Operations | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712 | IGF::CL,CT::IGF RESEARCH AND DEVELOPMENT SERVICES FOR THE DEPARTMENT OF HOMELAND SECURITY, SCIENCE AND TECHNOLOGY DIRECTORATE, CHEMICAL AND BIOLOGICAL DEFENSE | $532,260 |
| 2017 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING STROMAL COLLAGEN IN PANCREATIC CANCER | $386,727 |
| 2017 | Centers for Disease Control and Prevention | Contract | OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690 | IGF::OT::IGF BIOINFORMATICS SUPPORT SERVICES | $364,145 |
| 2017 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | CATT: DEVELOPMENT AND APPLICATION OF A NEURONAL CELL ACTIVITY-TAGGING TOOLBOX | $300,969 |
| 2017 | Centers for Disease Control and Prevention | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711 | IGF::OT::IGF BAA 2017 | $109,504 |
| 2016 | Office of Procurement Operations | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712 | IGF::CL,CT::IGF RESEARCH AND DEVELOPMENT SERVICES FOR THE DEPARTMENT OF HOMELAND SECURITY, SCIENCE AND TECHNOLOGY DIRECTORATE, CHEMICAL AND BIOLOGICAL DEFENSE | $1,349,000 |
| 2016 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | EXRNA SIGNATURES PREDICT OUTCOMES AFTER BRAIN INJURY | $948,972 |
| 2016 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | SYSTEMATIC DEVELOPMENT OF NOVEL, DRUGGABLE CANCER TARGETS | $794,238 |
| 2016 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING STROMAL COLLAGEN IN PANCREATIC CANCER | $386,727 |
| 2016 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | RAPID EMERGENCE OF LIVESTOCK-ASSOCIATED MRSA ST398: HOST-ADAPTATION & VIRULENCE | $383,933 |
| 2016 | Centers for Disease Control and Prevention | Contract | OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690 | IGF::OT::IGF BIOINFORMATICS SUPPORT SERVICES | $356,463 |
| 2016 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | CATT: DEVELOPMENT AND APPLICATION OF A NEURONAL CELL ACTIVITY-TAGGING TOOLBOX | $345,473 |
| 2016 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING PHD2 IN PANCREATIC CANCER | $242,730 |
| 2016 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDE 93.853 | IDENTIFICATION OF PATHOGENIC MECHANISMS IMPORTANT IN MULTIPLE SYSTEM ATROPHY | $139,500 |
| 2015 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | EXRNA SIGNATURES PREDICT OUTCOMES AFTER BRAIN INJURY | $1,054,051 |
| 2015 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | SYSTEMATIC DEVELOPMENT OF NOVEL, DRUGGABLE CANCER TARGETS | $805,604 |
| 2015 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GENETIC DETERMINANTS OF NAFLD SEVERITY AND PROGRESSION | $498,594 |
| 2015 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDE 93.853 | IDENTIFICATION OF PATHOGENIC MECHANISMS IMPORTANT IN MULTIPLE SYSTEM ATROPHY | $403,647 |
| 2015 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TWEAK-FN14 HTS COMPOUND SCREENING | $390,619 |
| 2015 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | RAPID EMERGENCE OF LIVESTOCK-ASSOCIATED MRSA ST398: HOST-ADAPTATION & VIRULENCE | $387,318 |
| 2015 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING STROMAL COLLAGEN IN PANCREATIC CANCER | $386,727 |
| 2015 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | CATT: DEVELOPMENT AND APPLICATION OF A NEURONAL CELL ACTIVITY-TAGGING TOOLBOX | $372,187 |
| 2015 | Centers for Disease Control and Prevention | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711 | IGF::OT::IGF DNA SEQUENCING AND BIOINFORMATICS SUPPORT | $347,043 |
| 2015 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING PHD2 IN PANCREATIC CANCER | $202,275 |
| 2015 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | FUNCTIONAL ANALYSIS OF REGIONS OF INTROGRESSION BETWEEN SPECIES OF COCCIDIOIDES | $106,895 |
| 2014 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | MOLECULAR ANTIBIOTIC RESISTANCE ARRAYS FOR CLINICAL MICROBIOLOGY LABORATORIES | $868,077 |
| 2014 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | SYSTEMATIC DEVELOPMENT OF NOVEL, DRUGGABLE CANCER TARGETS | $788,540 |
| 2014 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | OPTIMIZATION AND NORMALIZATION STUDIES FOR CSF AS A BIOMARKER | $590,425 |
| 2014 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GENETIC DETERMINANTS OF NAFLD SEVERITY AND PROGRESSION | $562,372 |
| 2014 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | GENETIC DETERMINANTS OF TOTAL CHOLESTEROL LEVELS IN AMERICAN INDIANS | $451,143 |
| 2014 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | RAPID EMERGENCE OF LIVESTOCK-ASSOCIATED MRSA ST398: HOST-ADAPTATION & VIRULENCE | $389,890 |
| 2014 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TWEAK-FN14 HTS COMPOUND SCREENING | $383,429 |
| 2014 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING STROMAL COLLAGEN IN PANCREATIC CANCER | $375,126 |
| 2014 | Centers for Disease Control and Prevention | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711 | IGF::OT::IGF DNA SEQUENCING AND BIOINFORMATICS SUPPORT | $339,996 |
| 2014 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | CATT: DEVELOPMENT AND APPLICATION OF A NEURONAL CELL ACTIVITY-TAGGING TOOLBOX | $328,198 |
| 2014 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | FUNCTIONAL ANALYSIS OF REGIONS OF INTROGRESSION BETWEEN SPECIES OF COCCIDIOIDES | $163,887 |
| 2013 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | MOLECULAR ANTIBIOTIC RESISTANCE ARRAYS FOR CLINICAL MICROBIOLOGY LABORATORIES | $960,677 |
| 2013 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | SYSTEMATIC DEVELOPMENT OF NOVEL, DRUGGABLE CANCER TARGETS | $783,005 |
| 2013 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | OPTIMIZATION AND NORMALIZATION STUDIES FOR CSF AS A BIOMARKER | $500,000 |
| 2013 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GENETIC DETERMINANTS OF NAFLD SEVERITY AND PROGRESSION | $473,592 |
| 2013 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | RAPID EMERGENCE OF LIVESTOCK-ASSOCIATED MRSA ST398: HOST-ADAPTATION & VIRULENCE | $438,971 |
| 2013 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | GENETIC DETERMINANTS OF TOTAL CHOLESTEROL LEVELS IN AMERICAN INDIANS | $438,253 |
| 2013 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TWEAK-FN14 HTS COMPOUND SCREENING | $421,457 |
| 2013 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING STROMAL COLLAGEN IN PANCREATIC CANCER | $408,227 |
| 2013 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | FUNCTIONAL GENOMIC ANALYSES OF EMERGING CRYPTOCOCCUS SUBTYPES IN NORTH AMERICA | $226,142 |
| 2013 | Department of Defense | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | DANGEROUS PATHOGENS DNA FORENSICS AND MOLECULAR EPIDEMIOLOGY | -$2 |
| 2012 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | MOLECULAR ANTIBIOTIC RESISTANCE ARRAYS FOR CLINICAL MICROBIOLOGY LABORATORIES | $978,843 |
| 2012 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | SYSTEMATIC DEVELOPMENT OF NOVEL, DRUGGABLE CANCER TARGETS | $887,144 |
| 2012 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GENETIC DETERMINANTS OF NAFLD SEVERITY AND PROGRESSION | $634,699 |
| 2012 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | GENETIC DETERMINANTS OF TOTAL CHOLESTEROL LEVELS IN AMERICAN INDIANS | $563,427 |
| 2012 | National Science Foundation | Grant or other assistance | BIOLOGICAL SCIENCES 47.074 | DIMENSIONS: COLLABORATIVE RESEARCH: THE TAXONOMIC, GENOMIC, AND FUNCTIONAL DIVERSITY OF SOIL CARBON DYNAMICS | $499,759 |
| 2012 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TARGETING THE FN14-RAC1 SIGNALING PATHWAY IN INVASIVE GLIOMAS | $336,935 |
| 2012 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | FUNCTIONAL GENOMIC ANALYSES OF EMERGING CRYPTOCOCCUS SUBTYPES IN NORTH AMERICA | $291,179 |
| 2012 | National Institutes of Health | Contract | OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690 | TRANSLATIONAL GENOMICS RESEARCH:1109601 | $284,356 |
| 2012 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | HIGH DEFINITION CLONAL ANALYSES OF ARCHIVAL PANCREATIC ADENOCARCINOMA SAMPLES | $235,448 |
| 2012 | National Institutes of Health | Contract | TESTING LABORATORIES 541380 | # 12-005447 - JS / TGEN | $6,324 |
| 2012 | Office of Procurement Operations | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711 | THE PURPOSE OF THIS COST REIMBURSEMENT CONTRACT VIA TO DEPARTMENT OF HOMELAND SECURITY (DHS) BROAD AGENCY ANNOUNCEMENT (BAA) 09-19 BACTERIAL AND VIRAL BIOFORENS | $2,879 |
| 2011 | Department of the Army | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | COLONIZATION AND EXTRAINTESTINAL INFECTION WITH MULTIDRUG RESISTANT E. COLI: IDENTIFYING COMMUNITY RESERVOIRS | $1,049,000 |
| 2011 | Department of Defense | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | "COLONIZATION AND EXTRAINTESTINAL INFECTION WITH MULTIDRUG RESISTANT E. COLI; IDENTIFYING OMMUNITY RESERVOIRS"1049 | $1,049,000 |
| 2011 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | MOLECULAR ANTIBIOTIC RESISTANCE ARRAYS FOR CLINICAL MICROBIOLOGY LABORATORIES | $889,235 |
| 2011 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | BURKHOLDERIA: INTERNATIONAL COLLABORATIVE DEVELOPMENT OF NOVEL DIAGNOSTICS | $886,515 |
| 2011 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GENETIC DETERMINANTS OF NAFLD SEVERITY AND PROGRESSION | $739,560 |
| 2011 | Office of Procurement Operations | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711 | THE PURPOSE OF THIS COST REIMBURSEMENT CONTRACT VIA TO DEPARTMENT OF HOMELAND SECURITY (DHS) BROAD AGENCY ANNOUNCEMENT (BAA) 09-19 BACTERIAL AND VIRAL BIOFORENS | $542,441 |
| 2011 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | GENETIC DETERMINANTS OF TOTAL CHOLESTEROL LEVELS IN AMERICAN INDIANS | $513,725 |
| 2011 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | GENOMIC ANALYSIS OF TUMOR CONTEXT VULNERABILITIES IN HUMAN METASTATIC MELANOMA | $405,722 |
| 2011 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | GENETIC VARIATION IN KIBRA AND ITS ROLE IN HUMAN EPISODIC MEMORY | $335,971 |
| 2011 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TARGETING THE FN14-RAC1 SIGNALING PATHWAY IN INVASIVE GLIOMAS | $291,648 |
| 2011 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | HIGH DEFINITION CLONAL ANALYSES OF ARCHIVAL PANCREATIC ADENOCARCINOMA SAMPLES | $249,584 |
| 2011 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | THERAPEUTIC TARGETS FOR VIRAL AND NON-VIRAL-ASSOCIATED ORAL NEOPLASMS | $209,138 |
| 2011 | National Science Foundation | Grant or other assistance | BIOLOGICAL SCIENCES 47.074 | COLLABORATIVE RESEARCH: A NEW PARADIGM FOR UNDERSTANDING HOW LEAF LITTER QUALITY AFFECTS STREAM ECOSYSTEMS | $151,207 |
| 2010 | National Institutes of Health | Grant or other assistance | TRANS-NIH RECOVERY ACT RESEARCH SUPPORT 93.701 | THE SOUTHWEST COMPREHENSIVE CENTER FOR DRUG DISCOVERY AND DEVELOPMENT | $2,700,503 |
| 2010 | National Institutes of Health | Grant or other assistance | TRANS-NIH RECOVERY ACT RESEARCH SUPPORT 93.701 | CANINE HEREDITARY CANCER CONSORTIUM: FROM BARK TO BEDSIDE | $2,139,485 |
| 2010 | Department of the Army | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | PROSPECTIVE MOLECULAR CHARACTERIZATION OF BURN WOUND COLONIZATION: NOVEL TOOLS AND ANALYSIS | $1,015,000 |
| 2010 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | BURKHOLDERIA: INTERNATIONAL COLLABORATIVE DEVELOPMENT OF NOVEL DIAGNOSTICS | $927,361 |
| 2010 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | MOLECULAR ANTIBIOTIC RESISTANCE ARRAYS FOR CLINICAL MICROBIOLOGY LABORATORIES | $875,000 |
| 2010 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | DATA PROCESSING AND VISUALIZATION FOR 1000 GENOMES | $710,820 |
| 2010 | Office of Procurement Operations | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711 | THE PURPOSE OF THIS COST REIMBURSEMENT CONTRACT VIA TO DEPARTMENT OF HOMELAND SECURITY (DHS) BROAD AGENCY ANNOUNCEMENT (BAA) 09-19 BACTERIAL AND VIRAL BIOFORENS | $568,297 |
| 2010 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | GENOMIC ANALYSIS OF TUMOR CONTEXT VULNERABILITIES IN HUMAN METASTATIC MELANOMA | $424,806 |
| 2010 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | GENETIC DETERMINANTS OF TOTAL CHOLESTEROL LEVELS IN AMERICAN INDIANS | $422,500 |
| 2010 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | GENETIC DETERMINANTS OF LIPID TRAITS IN TYPE 2 DIABETES MELLITUS | $415,103 |
| 2010 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | GENETIC VARIATION IN KIBRA AND ITS ROLE IN HUMAN EPISODIC MEMORY | $338,818 |
| 2010 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | AURORA KINASES AS THERAPEUTIC TARGETS IN PANCREATIC CANCER | $316,242 |
| 2010 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TARGETING THE FN14-RAC1 SIGNALING PATHWAY IN INVASIVE GLIOMAS | $300,668 |
| 2010 | Health Resources and Services Administration | Grant or other assistance | HEALTH CARE AND OTHER FACILITIES 93.887 | HEALTH CARE AND OTHER FACILITIES | $297,000 |
| 2010 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | HIGH DEFINITION CLONAL ANALYSES OF ARCHIVAL PANCREATIC ADENOCARCINOMA SAMPLES | $257,303 |
| 2010 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | THERAPEUTIC TARGETS FOR VIRAL AND NON-VIRAL-ASSOCIATED ORAL NEOPLASMS | $253,500 |
| 2010 | National Institutes of Health | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711 | TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (10-004519) | $250,000 |
State business registration
- THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE AZ, Employee benefit plan sponsor (Form 5500), Filed for plan year 2025
The same business name in the same state, from the state’s official registry data.
Patents
123 US patents filed in the last 20 years.
- The Translational Genomics Research Institute 123 patents, 2010-10-19 to 2026-10-20 FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12767977 | Methods and kits for the detection of SARS-CoV-2 | 2026-10-20 | PTBLXML, file of 2026-10-20 |
| US 12674200 | Methods and kits for the detection of SARS-CoV-2 | 2026-07-07 | PTBLXML, file of 2026-07-07 |
| US 12653803 | TREM2 agonists for the stimulation of microglia and methods of identification | 2026-06-16 | PTBLXML, file of 2026-06-16 |
| US 12637725 | Methods, oligonucleotides, and kits for detection and treatment of coronavirus | 2026-05-26 | PTBLXML, file of 2026-05-26 |
| US 12571046 | Methods of detecting and treating multiple system atrophy | 2026-03-10 | PTBLXML, file of 2026-03-10 |
| US 12529108 | Compositions, methods and kits for characterizing and screening for small cell ovarian carcinoma | 2026-01-20 | PTBLXML, file of 2026-01-20 |
| US 12522877 | Early detection of drug-resistant mycobacterium tuberculosis | 2026-01-13 | PTBLXML, file of 2026-01-13 |
| US 12478290 | Systems, methods, and devices for rotating insulin administration sites | 2025-11-25 | PVGPATDIS, file of 2026-04-10 |
| US 12467075 | Method for validating assays of biological samples | 2025-11-11 | PVGPATDIS, file of 2026-04-10 |
| US 12404558 | Methods and assays for detection and subtyping of microbial pathogens | 2025-09-02 | PVGPATDIS, file of 2026-04-10 |
The newest patents of the PatentsView assignees above, matched to this record by name (and state).
Trademarks
45 US trademarks, 16 live.
- The Translational Genomics Research Institute 45 marks, AZ FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
| Mark | Serial | Filed | Status | Source |
|---|---|---|---|---|
| MINDCROWD | 97920247 | 2023-05-04 | Registered | TRTYRAP, file of 2026-04-03 |
| VIDIUM | 97151014 | 2021-12-01 | Registered | TRCFECO2, file of 2024-03-27 |
| SPOTLIGHT | 97045049 | 2021-09-25 | Registered | TRCFECO2, file of 2024-03-27 |
| SEARCHLIGHT DNA | 90130097 | 2020-08-21 | Registered | TRTDXFAP, file of 2026-06-24 |
| VIDIUM ANIMAL HEALTH | 90130068 | 2020-08-21 | Registered | TRTDXFAP, file of 2026-05-06 |
| PROFERO | 88000887 | 2018-06-14 | Abandoned | TRCFECO2, file of 2024-03-27 |
| GEM EXTRA | 87917606 | 2018-05-11 | Registration cancelled | TRTDXFAP, file of 2026-03-04 |
| LYMESEQ | 87144797 | 2016-08-19 | Abandoned | TRCFECO2, file of 2024-03-27 |
| ID ORIGINS | 86929082 | 2016-03-04 | Abandoned | TRCFECO2, file of 2024-03-27 |
| CIRRASPEC | 86929017 | 2016-03-04 | Registered | TRTDXFAP, file of 2025-08-11 |
The newest marks of the trademark owners above, matched to this record by name (and state).
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE | AZ | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Payment recipient | THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE | AZ | Open Payments (drug and device company payments) | name and state |
| Payment recipient | TRANSLATIONAL GENOMICS RESEARCH INSTITUTE | AZ | Open Payments (drug and device company payments) | name and state |
Matched by name (and state) or EIN only; a shared name is not proof of the same person or organization.
Comments